/artkey/inf-999901-0001_Pokyny_autorum_-_Klinicka_farmakologie_a_farmacie.php weekly 0.3 /artkey/inf-999901-0002_Klinicka_farmakologie_a_farmacie.php weekly 0.3 /artkey/inf-999901-0010_Inzerce.php weekly 0.3 /artkey/inf-999901-0011_Kontakty.php weekly 0.3 /artkey/inf-888800-0003_Predstaveni_spolecnosti_Solen.php weekly 0.3 /artkey/inf-888800-0005_redakcni_prace.php weekly 0.3 /artkey/inf-888800-0006_Odborne_akce_na_8222_klic_8220_-_komplexni_servis.php weekly 0.3 /artkey/inf-888800-0007_Graficke_a_tiskove_prace.php weekly 0.3 /artkey/inf-999901-0021_Instructions_for_authors.php weekly 0.3 /artkey/inf-999901-0022_About.php weekly 0.3 /artkey/inf-999901-0023_Editorial_board.php weekly 0.3 /artkey/inf-999901-0031_Contacts.php weekly 0.3 /artkey/inf-990000-2300_Publikacni_etika.php weekly 0.3 /artkey/inf-990000-2400_Publication_ethics.php weekly 0.3 /artkey/inf-999901-0032_Objednavka_casopisu.php weekly 0.3 /artkey/inf-990000-9400_Solen_-_About_Us.php weekly 0.3 /artkey/inf-990000-9500_Educational_Events.php weekly 0.3 /artkey/inf-990000-9700_Kontakty.php weekly 0.3 /artkey/inf-990001-0100_Nabidka_sluzeb.php weekly 0.3 /artkey/inf-990001-0200_Odpovedna_firma.php weekly 0.3 /artkey/inf-990001-7800_Reference.php weekly 0.3 /artkey/inz-990000-0200_Vlozit_inzerat.php weekly 0.3 /artkey/inz-990000-0300_Zakladni_informace.php weekly 0.3 /artkey/inz-990000-0400_Kontakty.php weekly 0.3 revartsetting.php weekly 0.3 /aktualni-akce.php?mag=far weekly 0.3 /rolrequest.php weekly 0.3 /personalni-inzerce weekly 0.3 / weekly 0.3 /casopisy.php weekly 0.3 /magorder.php weekly 0.3 /akce-na-klic.php weekly 0.3 /current_issue.php daily 0.7 /archive.php daily 0.7 /magno/far/2025/mn1.php weekly 0.7 /flashbook/far/2025/1.php monthly 0.2 /artkey/far-202501-0006_rozdily_mezi_pohlavimi_-_od_farmakologie_az_po_metodologii_klinickeho_vyzkumu.php weekly 0.7 /artkey/far-202501-0007_pouziti_terapeutickeho_monitorovani_hladin_antipsychotik_druhe_generace_pri_individualizaci_farmakoterapie_schi.php weekly 0.7 /artkey/far-202501-0008_psychedelika_v_terapii_cluster_headache.php weekly 0.7 /artkey/far-202501-0009_slovo_uvodem.php weekly 0.7 /artkey/far-202501-0003_farmakokineticke_lekove_interakce_primo_pusobicich_peroralnich_antikoagulancii.php weekly 0.7 /artkey/far-202501-0004_lekove_interakce_doac_a_protizachvatovych_leku.php weekly 0.7 /artkey/far-202501-0005_interakce_leku_uzivanych_k_terapii_hyperaktivniho_mocoveho_mechyre.php weekly 0.7 /artkey/far-202501-0001_klinicky_vyznamne_liekove_interakcie_pri_podavani_nirmatrelviru_ritonaviru_u_pacientov_s_chronickou_farmakotera.php weekly 0.7 /artkey/far-202501-0002_hypolipidemicka_liecba_inklisiranom_skusenosti_jedneho_slovenskeho_pracoviska.php weekly 0.7 /magno/far/2025/mn2.php weekly 0.7 /flashbook/far/2025/2.php monthly 0.2 /artkey/far-202502-0005_strucny_prehled_farmakoterapie_v_paliativni_medicine_-_cast_prvni.php weekly 0.7 /artkey/far-202502-0006_antidepresiva_v_lecbe_depresivni_poruchy_v_tehotenstvi_lecit_nebo_nelecit.php weekly 0.7 /artkey/far-202502-0007_postaveni_glukokortikoidu_v_revmatologii.php weekly 0.7 /artkey/far-202502-0008_konzervativni_lecba_endometriozy.php weekly 0.7 /artkey/far-202502-0009_retatrutid_novy_pristup_v_lecbe_obezity_diabetu_mellitu_a_masld_metabolic_dysfunction-associated_steatotic_l.php weekly 0.7 /artkey/far-202502-0010_slovo_uvodem.php weekly 0.7 /artkey/far-202502-0002_bezpecnost_biologicke_a_cilene_lecby_v_revmatologii.php weekly 0.7 /artkey/far-202502-0003_nezadouci_ucinky_systemove_lecby_psoriazy.php weekly 0.7 /artkey/far-202502-0004_primum_non_nocere_jak_bezpecna_je_moderni_terapie_roztrousene_sklerozy.php weekly 0.7 /artkey/far-202502-0001_metformin_a_deficit_vitaminu_b12_-_vlastni_pozorovani_z_klinicke_praxe.php weekly 0.7 /magno/far/2025/mn4.php weekly 0.7 /flashbook/far/2025/4.php monthly 0.2 /artkey/far-202504-0008_lecba_polymorbidnich_pacientu_s_roztrousenou_sklerozou.php weekly 0.7 /artkey/far-202504-0009_nitazeny_a_dalsi_superagoniste_opioidnich_receptoru.php weekly 0.7 /artkey/far-202504-0010_ucinnost_a_bezpecnost_fezolinetantu_v_lecbe_stredne_tezkych_az_silnych_vazomotorickych_symptomu_u_zen_u_kteryc.php weekly 0.7 /artkey/far-202504-0001_betablokatory_v_kardiologii_editorial.php weekly 0.7 /artkey/far-202504-0011_farmakokineticke_interakce_klozapinu_a_olanzapinu_kazuistiky_lekovych_zmen_pri_inhibici_cyp1a2.php weekly 0.7 /artkey/far-202504-0003_betablokatory_u_akutniho_koronarniho_syndromu_soucasne_dukazy_a_klinicke_implikace.php weekly 0.7 /artkey/far-202504-0004_betablokatory_v_lecbe_chronicke_ischemicke_choroby_srdecni.php weekly 0.7 /artkey/far-202504-0005_betablokatory_v_lecbe_arterialni_hypertenze.php weekly 0.7 /artkey/far-202504-0006_betablokatory_v_lecbe_poruch_srdecniho_rytmu.php weekly 0.7 /artkey/far-202504-0007_betablokatory_v_lecbe_srdecniho_selhani.php weekly 0.7 /artkey/far-202504-0002_retrospektivna_analyza_krvacavych_prihod_a_extremnych_inr_v_populacii_zosnulych_pacientov.php weekly 0.7 /magno/far/2025/mn5.php weekly 0.7 /flashbook/far/2025/5.php monthly 0.2 /artkey/far-202505-0007_farmakoterapie_neuropaticke_bolesti.php weekly 0.7 /artkey/far-202505-0008_strucny_prehled_farmakoterapie_v_paliativni_medicine_-_cast_druha.php weekly 0.7 /artkey/far-202505-0009_vazoaktivni_leky_v_lecbe_erektilni_dysfunkce_soucasne_koncepty.php weekly 0.7 /artkey/far-202505-0010_dapagliflozin_v_lecbe_iga_nefropatie_u_pediatrickeho_pacienta.php weekly 0.7 /artkey/far-202505-0011_vyber_vhodneho_mocoveho_spasmolytika_u_geriatricke_pacientky.php weekly 0.7 /artkey/far-202505-0003_vyznam_terapeutickeho_monitorovani_teofylinu.php weekly 0.7 /artkey/far-202505-0004_tdm_jako_nastroj_pro_farmakogeneticke_profilovani_pacientu_kazuistika_fenokonverze.php weekly 0.7 /artkey/far-202505-0005_navozeni_indukce_cyp3a4_metamizolem_potvrzene_metodou_tdm_pripadova_studie_s_kvetiapinem.php weekly 0.7 /artkey/far-202505-0006_linezolid_a_terapeuticke_monitorovani_nastal_cas_pro_rutinni_tdm.php weekly 0.7 /artkey/far-202505-0001_uvodni_slovo_k_tematu_cisla.php weekly 0.7 /artkey/far-202505-0002_retrospektivna_analyza_ucinnosti_remdesiviru_v_liecbe_ochorenia_covid-19_pocas_druhej_pandemickej_vlny.php weekly 0.7 /magno/far/2024/mn1.php weekly 0.7 /flashbook/far/2024/1.php monthly 0.2 /artkey/far-202401-0008_problematika_adherence_k_farmakoterapii_z_pohledu_psychiatra.php weekly 0.7 /artkey/far-202401-0003_adherencia_k_liecbe_-_cesta_k_pochopeniu_pacienta.php weekly 0.7 /artkey/far-202401-0004_hypertenzna_choroba_v_kontexte_adherencie_a_nonadherencie_k_liecbe.php weekly 0.7 /artkey/far-202401-0005_adherence_k_lecbe_u_chronickych_plicnich_chorob_se_zamerenim_na_chopn.php weekly 0.7 /artkey/far-202401-0006_efektivni_intervence_ke_zvyseni_adherence_k_inhalacni_terapii_pacientu_s_bronchialnim_astmatem.php weekly 0.7 /artkey/far-202401-0001_betablokatory_a_kardiovaskularni_onemocneni_-_kontroverze_2023.php weekly 0.7 /artkey/far-202401-0007_farmakologicky_profil_mavakamtenu_v_lecbe_hypertroficke_obstrukcni_kardiomyopatie.php weekly 0.7 /artkey/far-202401-0002_pochybeni_vyskytujici_se_pri_podani_leciv_sestrou_hospitalizovanym_pacientum_observacne-intervencni_studie.php weekly 0.7 /magno/far/2024/mn2.php weekly 0.7 /flashbook/far/2024/2.php monthly 0.2 /artkey/far-202402-0005_klinicky_aspekt_poskytovania_lekarenskej_starostlivosti_vo_verejnych_lekarnach.php weekly 0.7 /artkey/far-202402-0006_moznosti_predchazeni_a_reseni_polypragmazie.php weekly 0.7 /artkey/far-202402-0007_farmaky_navozeny_psychoticky_syndrom.php weekly 0.7 /artkey/far-202402-0008_slovo_uvodem.php weekly 0.7 /artkey/far-202402-0002_moderni_farmakoterapie_alzheimerovy_nemoci.php weekly 0.7 /artkey/far-202402-0003_moderni_farmakoterapie_parkinsonovy_nemoci.php weekly 0.7 /artkey/far-202402-0004_role_farmakoterapie_v_lecbe_amyotroficke_lateralni_sklerozy.php weekly 0.7 /artkey/far-202402-0001_zhodnoceni_incidence_unlicensed_a_off-label_predpisu_leciv_u_deti.php weekly 0.7 /magno/far/2024/mn3.php weekly 0.7 /flashbook/far/2024/3.php monthly 0.2 /artkey/far-202403-0006_role_studijniho_koordinatora_v_klinickem_vyzkumu_ve_zdravotnickych_zarizenich_-_popelka_mezi_experty_v_klinicky.php weekly 0.7 /artkey/far-202403-0005_vazebne_sily_typy_interakci_leciv_s_molekulovymi_cili_v_organismu.php weekly 0.7 /artkey/far-202403-0002_importance_and_safety_of_magnesium_supplementation_in_pregnancy_to_supplement_or_not.php weekly 0.7 /artkey/far-202403-0003_soucasne_trendy_v_terapii_bolesti_u_popalenych_pacientu_opioidni_neopioidni_a_nefarmakologicke_ovlivneni_bole.php weekly 0.7 /artkey/far-202403-0004_biologicke_ucinky_pomocnych_latek_pouzivanych_u_intravenozne_podavanych_leciv.php weekly 0.7 /artkey/far-202403-0001_hodnotenie_liekovych_interakcii_u_pacientov_s_kardiovaskularnymi_ochoreniami_a_diabetes_mellitus_2_typu_pri_po.php weekly 0.7 /magno/far/2024/mn4.php weekly 0.7 /flashbook/far/2024/4.php monthly 0.2 /artkey/far-202404-0003_komplexna_terapia_bolesti_u_detskych_pacientov_s_popaleninami_kombinacia_farmakologickych_a_nefarmakologickych.php weekly 0.7 /artkey/far-202404-0004_molekularni_mechanismy_a_farmakologie_kanabinoidu_od_teorie_k_praxi.php weekly 0.7 /artkey/far-202404-0005_vzdelavani_lekaru_v_oboru_klinicka_farmakologie.php weekly 0.7 /artkey/far-202404-0002_farmakologicky_profil_fosfomycinu.php weekly 0.7 /artkey/far-202404-0001_prinos_inovativnej_terapie_u_pacientov_s_cystickou_fibrozou.php weekly 0.7 /magno/far/2023/mn1.php weekly 0.7 /flashbook/far/2023/1.php monthly 0.2 /artkey/far-202301-0005_finerenon_farmakologicky_profil.php weekly 0.7 /artkey/far-202301-0006_farmakokineticke_vlastnosti_flukloxacilinu.php weekly 0.7 /artkey/far-202301-0007_subkutanni_infliximab_v_lecbe_ankylozujici_spondylitidy.php weekly 0.7 /artkey/far-202301-0001_soucasne_trendy_ve_farmakoterapii_erektilni_dysfunkce.php weekly 0.7 /artkey/far-202301-0002_co_je_nove_vo_farmakoterapii_benignej_hyperplazie_prostaty.php weekly 0.7 /artkey/far-202301-0003_lekove_interakce_farmak_pouzivanych_pri_terapii_erektilni_dysfunkce_s_doplnky_stravy.php weekly 0.7 /artkey/far-202301-0004_lecba_urotelialniho_karcinomu_mocoveho_mechyre.php weekly 0.7 /artkey/far-202301-0008_rok_2023_a_roky_koncici_cislici_tri.php weekly 0.7 /magno/far/2023/mn2.php weekly 0.7 /flashbook/far/2023/2.php monthly 0.2 /artkey/far-202302-0005_tirzepatid_-_nova_nadeje_v_lecbe_obezity_a_nove_antidiabetikum.php weekly 0.7 /artkey/far-202302-0006_rizika_uzivani_opioidu_u_senioru_s_perzistujici_bolesti.php weekly 0.7 /artkey/far-202302-0007_switch_pacienta_s_ulcerozni_kolitidou_na_subkutanni_infliximab_pro_recidivujici_infekce_hornich_cest_dychacich.php weekly 0.7 /artkey/far-202302-0008_limitace_ucinnosti_idarucizumabu_pri_akutnim_renalnim_selhani_-_kazuistika.php weekly 0.7 /artkey/far-202302-0003_farmakoterapie_hypertenze_v_tehotenstvi.php weekly 0.7 /artkey/far-202302-0004_trastuzumabem_indukovana_kardiotoxicita_prehled.php weekly 0.7 /artkey/far-202302-0001_nejvyznamnejsi_enzymy_druhe_faze_metabolismu_leciv_udp-glukuronosyltransferazy_a_sulfotransferazy.php weekly 0.7 /artkey/far-202302-0002_analyza_farmakoterapie_crohnovej_choroby_v_pediatrickej_a_dospelej_populacii.php weekly 0.7 /magno/far/2023/mn3.php weekly 0.7 /flashbook/far/2023/3.php monthly 0.2 /artkey/far-202303-0005_liecba_dny_vyuzitie_klasickej_a_novej_farmakoterapie.php weekly 0.7 /artkey/far-202303-0006_inklisiran_-_novy_reprezentant_biologicke_lecby_dyslipidemie.php weekly 0.7 /artkey/far-202303-0007_lokalna_liecba_bazocelularneho_karcinomu_-_sucasny_stav_a_nove_perspektivy.php weekly 0.7 /artkey/far-202303-0008_nivolumab_v_kombinaci_s_chemoterapii_nebo_ipilimumabem_v_prvni_linii_paliativni_lecby_zhoubnych_nadoru_jicnu_g.php weekly 0.7 /artkey/far-202303-0009_dlouhodoba_lecebna_odpoved_na_lecbu_nivolumabem_a_chemoterapii_u_pacientu_s_adenokarcinomem_zaludku_a_gastroezo.php weekly 0.7 /artkey/far-202303-0003_individualni_farmakokineticke_modelovani_a_terapeuticke_monitorovani_leku.php weekly 0.7 /artkey/far-202303-0004_populacni_pristup_ve_farmakokineticke_analyze.php weekly 0.7 /artkey/far-202303-0001_the_importance_of_a_fast-track_pharmacology_for_the_proper_management_of_antibiotic_therapy_in_intensive_care_u.php weekly 0.7 /artkey/far-202303-0011_23_ceska_konference_klinicke_farmakologie_olomouc_7_8211_9_zari_2023.php weekly 0.7 /artkey/far-202303-0002_stanoveni_kolistinu_a_b_a_kolistin-methanesulfonatu_v_lidske_plazme_pomoci_lc-ms_ms_a_jejich_kratkodoba_stabil.php weekly 0.7 /artkey/far-202303-0010_vybrana_abstrakta_z_23_ceske_konference_klinicke_farmakologieteoreticke_ustavy_lf_up_v_olomouci7_8211_9_zar.php weekly 0.7 /magno/far/2023/mn4.php weekly 0.7 /flashbook/far/2023/4.php monthly 0.2 /artkey/far-202304-0004_bolest_u_neurologickych_nemoci_z_povolani.php weekly 0.7 /artkey/far-202304-0005_chirurgicka_liecba_gynekomastie_vyvolanej_bikalutamidom_prehlad_vybranych_liekov_sp_sobujucich_neziaduce_ucink.php weekly 0.7 /artkey/far-202304-0001_editorial.php weekly 0.7 /artkey/far-202304-0002_kyselina_fytova_-_skodi_ci_pomaha.php weekly 0.7 /artkey/far-202304-0003_intoxikace_blokatory_kalciovych_kanalu.php weekly 0.7 /magno/far/2022/mn1.php weekly 0.7 /flashbook/far/2022/1.php monthly 0.2 /artkey/far-202201-0001_stanoveni_plazmatickych_koncentraci_ampicilinu_pri_jednorazovem_podani_v_kardiochirurgicke_profylaxi.php weekly 0.7 /artkey/far-202201-0002_zasady_podavani_vybranych_lecivych_pripravku_z_pohledu_znalosti_studentu.php weekly 0.7 /artkey/far-202201-0006_fyzikalne-chemicke_vlastnosti_kolistinu_a_jejich_dopady_do_klinicke_praxe.php weekly 0.7 /artkey/far-202201-0007_slovo_uvodem.php weekly 0.7 /artkey/far-202201-0003_lecba_pooperacni_bolesti.php weekly 0.7 /artkey/far-202201-0004_pooperacni_nauzea_a_zvraceni.php weekly 0.7 /artkey/far-202201-0005_antifibrinolytika_a_jejich_pouziti_v_kardiochirurgii.php weekly 0.7 /magno/far/2022/mn2.php weekly 0.7 /flashbook/far/2022/2.php monthly 0.2 /artkey/far-202202-0004_analyza_nakladove_efektivity_biologickych_leciv_v_lecbe_stredne_tezke_az_tezke_loziskove_psoriazy_z_perspektivy.php weekly 0.7 /artkey/far-202202-0005_melatonin_v_manazmente_poruch_spanku_asociovanych_s_atopickou_dermatitidou_-_od_teorie_k_praxi.php weekly 0.7 /artkey/far-202202-0006_preventivna_liecba_migreny_u_starsich_pacientov_-_je_nova_biologicka_liecba_svetlo_na_konci_tunela.php weekly 0.7 /artkey/far-202202-0001_klinicke_zkusenosti_s_facilitovanym_podavanim_imunoglobulinove_substitucni_lecby.php weekly 0.7 /artkey/far-202202-0002_lanadelumab_v_terapii_hereditarniho_angioedemu.php weekly 0.7 /artkey/far-202202-0003_je_mozno_ovlivnit_vznik_a_prubeh_infekce_covid-19_vysledky_studie_u_zdravotniku_ve_fn_ostrava.php weekly 0.7 /artkey/far-202202-0007_vericigvat_farmakologicky_profil.php weekly 0.7 /magno/far/2022/mn3.php weekly 0.7 /flashbook/far/2022/3.php monthly 0.2 /artkey/far-202203-0001_porovnani_mw_pharm_3_30_dos_a_mw_pharm_windows_verze_farmakokinetickeho_softwaru_pro_pk_pd_modelovani_hl.php weekly 0.7 /artkey/far-202203-0005_neonatalni_abstinencni_syndrom_okenko_nejnovejsi_zahranicni_praxe_lecby.php weekly 0.7 /artkey/far-202203-0006_otrava_lerkanidipinem.php weekly 0.7 /artkey/far-202203-0002_je_mozna_farmakologicka_eradikace_hiv.php weekly 0.7 /artkey/far-202203-0003_post-covid-19_plucna_fibroza_a_moznosti_jej_liecby.php weekly 0.7 /artkey/far-202203-0004_vyuziti_taurolidinu_v_prevenci_a_lecbe_katetrovych_infekci.php weekly 0.7 /artkey/far-202203-0007_vzpominky_na_prof_rndr_jaroslava_kvetinu_drsc_dr_h_c.php weekly 0.7 /magno/far/2022/mn4.php weekly 0.7 /flashbook/far/2022/4.php monthly 0.2 /artkey/far-202204-0004_bezpecnost_podavani_leciv_sestrou_pacientum_v_luzkovych_zdravotnickych_zarizenich_prehled_literatury.php weekly 0.7 /artkey/far-202204-0005_aktualni_poznatky_ve_vyzkumu_silymarinu_a_jeho_komponent.php weekly 0.7 /artkey/far-202204-0006_opetovne_nasazeni_klozapinu.php weekly 0.7 /artkey/far-202204-0007_rozvoj_klicovych_kompetenci_v_oblasti_klinickeho_vyzkumu_conscious_curriculum_projects.php weekly 0.7 /artkey/far-202204-0001_co_je_noveho_v_terapii_migreny.php weekly 0.7 /artkey/far-202204-0002_vyznam_terapeutickeho_monitorovani_leciv_pri_optimalizaci_davkovani_acykloviru.php weekly 0.7 /artkey/far-202204-0003_polekove_tresy.php weekly 0.7 /magno/far/2021/mn1.php weekly 0.7 /flashbook/far/2021/1.php monthly 0.2 /artkey/far-202101-0001_poskytovani_klinickofarmaceuticke_pece_na_klinice_infekcnich_nemoci_behem_prvni_vlny_pandemie_covid-19_-_zkusen.php weekly 0.7 /artkey/far-202101-0005_sucasny_pohlad_na_pneumokokovu_vakcinaciu_u_dospelych_preco_nesmieme_zabudat_na_konjugovanu_vakcinu.php weekly 0.7 /artkey/far-202101-0008_tricaty_paty_rocnik_casopisu_klinicka_farmakologie_a_8239_farmacie.php weekly 0.7 /artkey/far-202101-0007_pripad_ceftriaxonem_indukovane_pseudolithiazy_zlucniku.php weekly 0.7 /artkey/far-202101-0002_farmakokineticke_a_farmakodynamicke_lekove_interakce_antiepileptik.php weekly 0.7 /artkey/far-202101-0003_vyznam_interakci_antiepileptik_v_rutinni_klinicke_praxi.php weekly 0.7 /artkey/far-202101-0004_analyticke_metody_pro_stanoveni_cefazolinu.php weekly 0.7 /artkey/far-202101-0009_prof_mudr_frantisek_perlik_drsc.php weekly 0.7 /artkey/far-202101-0006_durvalumab_v_lecbe_nemalobunecneho_karcinomu_plic.php weekly 0.7 /magno/far/2021/mn2.php weekly 0.7 /flashbook/far/2021/2.php monthly 0.2 /artkey/far-202102-0006_lekove_interakce_antiepileptik_cast_2_-_interakce_s_leky_z_jinych_indikacnich_skupin.php weekly 0.7 /artkey/far-202102-0007_oralne_prejavy_farmakologickej_liecby_systemovych_ochoreni.php weekly 0.7 /artkey/far-202102-0008_metamizol_dipyron.php weekly 0.7 /artkey/far-202102-0009_dyskinezy_vyvolane_fixnou_kombinaciou_orfenadrin_diklofenak_u_dvoch_pacientok_s_pokrocilou_parkinsonovou_chorob.php weekly 0.7 /artkey/far-202102-0002_moderni_trendy_ve_farmakologicke_lecbe_srdecniho_selhani.php weekly 0.7 /artkey/far-202102-0003_kardiovaskularni_nezadouci_ucinky_protinadorove_lecby.php weekly 0.7 /artkey/far-202102-0004_ateroskleroticka_kardiovaskularni_onemocneni_a_klinicky_vyznam_lecby_inclisiranem.php weekly 0.7 /artkey/far-202102-0005_chronoterapia_hypertenzie_vecerna_aplikacia_antihypertenziv_ako_realny_determinant_kardiovaskularnej_prognozy.php weekly 0.7 /artkey/far-202102-0001_vliv_kyseliny_valproove_na_hladinu_karbamazepinu_a_karbamazepin-10_11-epoxidu_pri_dlouhodobe_lecbe_pripravky_s.php weekly 0.7 /magno/far/2021/mn3.php weekly 0.7 /flashbook/far/2021/3.php monthly 0.2 /artkey/far-202103-0001_analyza_spotreby_antibiotik_v_ceske_republice_a_jeji_zavery_pro_klinickou_praxi.php weekly 0.7 /artkey/far-202103-0005_lekove_interakce_antiepileptik_cast_3_-_interakce_s_hormonalni_antikoncepci.php weekly 0.7 /artkey/far-202103-0006_nintedanib_v_lecbe_intersticialniho_plicniho_onemocneni_asociovaneho_se_systemovou_sklerodermii.php weekly 0.7 /artkey/far-202103-0002_lecba_pacientu_pripravkem_bunecne_terapie_axikabtagen_ciloleucel.php weekly 0.7 /artkey/far-202103-0003_soucasne_trendy_v_lecbe_akutni_myeloidni_leukemie_-_od_indukcni_chemoterapie_7_3_po_cilenou_lecbu.php weekly 0.7 /artkey/far-202103-0004_lecba_mnohocetneho_myelomu_v_roce_2021.php weekly 0.7 /artkey/far-202103-0007_9_cesko_8209_slovenska_konferencia_klinickej_farmakologie_-_abstrakta.php weekly 0.7 /magno/far/2021/mn4.php weekly 0.7 /flashbook/far/2021/4.php monthly 0.2 /artkey/far-202104-0005_nove_trendy_v_pristupu_k_lecbe_diabetu_2_typu_-_postrehy_a_benefity_v_ambulantni_praxi_diabetologa.php weekly 0.7 /artkey/far-202104-0007_dulezitost_volby_enhanceru_penetrace_v_topickych_lecivych_pripravcich.php weekly 0.7 /artkey/far-202104-0001_dobre_zpravy_ze_spatne_doby.php weekly 0.7 /artkey/far-202104-0002_antitromboticka_lecba_u_antifosfolipidoveho_syndromu_postaveni_primych_antikoagulancii.php weekly 0.7 /artkey/far-202104-0003_revmaticke_nezadouci_ucinky_imunoterapie_nadorovych_onemocneni_inhibitory_kontrolniho_bodu_imunitnich_reakci.php weekly 0.7 /artkey/far-202104-0004_obtizne_lecitelna_psoriaticka_artritida_-_kazuistika.php weekly 0.7 /artkey/far-202104-0006_komentar_k_clanku_8222_nove_trendy_v_pristupu_k_lecbe_diabetu_2_typu_-postrehy_a_benefity_v_ambulantni_praxi.php weekly 0.7 /magno/far/2020/mn1.php weekly 0.7 /flashbook/far/2020/1.php monthly 0.2 /artkey/far-202001-0002_lekove_alergie_a_kvalita_odebrane_anamnezy_u_hospitalizovanych_pacientu.php weekly 0.7 /artkey/far-202001-0006_alogenni_transplantace_hemopoetickych_bunek_z_pohledu_farmakoterapie.php weekly 0.7 /artkey/far-202001-0007_nezadouci_ucinky_leku_na_kuzi_-_alergicke_projevy.php weekly 0.7 /artkey/far-202001-0008_nezadouci_ucinky_derivatu_platiny_podavanych_metodou_hipec.php weekly 0.7 /artkey/far-202001-0009_anticholinergika_pouzivane_v_liecbe_hyperaktivneho_mocoveho_mechura_a_vplyv_na_kognitivne_funkcie_starsich_paci.php weekly 0.7 /artkey/far-202001-0003_lokalni_anestetika_v_zubnim_lekarstvi.php weekly 0.7 /artkey/far-202001-0004_nova_moznost_lokalni_anestezie_v_zubnim_lekarstvi.php weekly 0.7 /artkey/far-202001-0005_pacienti_s_antikoagulacni_terapii_v_ordinaci_stomatochirurga_-_schema_osetreni.php weekly 0.7 /artkey/far-202001-0001_klinicka_farmakologie_mezi_dvema_svety_v_dobe_krize.php weekly 0.7 /artkey/far-202001-0010_klinicka_farmakologie_a_farmacie_c_1_2020.php weekly 0.7 /magno/far/2020/mn2.php weekly 0.7 /flashbook/far/2020/2.php monthly 0.2 /artkey/far-202002-0004_vliv_genetickych_a_epigenetickych_faktoru_jako_kovariatu_snasenlivosti_a_lecebne_odpovedi_na_olanzapin_v_terapi.php weekly 0.7 /artkey/far-202002-0005_biosimilarni_infliximab_v_pediatrii.php weekly 0.7 /artkey/far-202002-0006_monoklonalni_protilatky_u_tehotnych_s_idiopatickymi_strevnimi_zanety.php weekly 0.7 /artkey/far-202002-0007_aktuality_vo_farmakoterapii_astmy_bronchiale.php weekly 0.7 /artkey/far-202002-0008_nova_prima_peroralni_antikoagulancia_-_nove_molekuly_ve_vyzkumu.php weekly 0.7 /artkey/far-202002-0009_klinicka_farmacie_v_pediatricke_paliativni_peci.php weekly 0.7 /artkey/far-202002-0001_klinicka_farmakologie_lekarska_odbornost_akademicka_disciplina_a_vedni_obor.php weekly 0.7 /artkey/far-202002-0002_terapeuticke_monitorovani_leciv_-_review.php weekly 0.7 /artkey/far-202002-0003_laboratorni_metody_v_terapeutickem_monitorovani_leku.php weekly 0.7 /artkey/far-202002-0010_klinicka_farmakologie_a_farmacie_c_2_2020.php weekly 0.7 /magno/far/2020/mn3.php weekly 0.7 /flashbook/far/2020/3.php monthly 0.2 /artkey/far-202003-0001_hodnoceni_geriatrickych_interakci_lek-nemoc_u_senioru_v_dlouhodobe_osetrovatelske_peci_v_ceske_republice.php weekly 0.7 /artkey/far-202003-0002_potrava_jako_dulezita_soucast_maximalizace_ucinku_a_minimalizace_rizik_farmakoterapie_-_absorpce_a_gastrointest.php weekly 0.7 /artkey/far-202003-0006_soucasny_pohled_na_podavani_intravenoznich_imunoglobulinu_u_pacientu_s_toxickou_epidermalni_nekrolyzou.php weekly 0.7 /artkey/far-202003-0007_neocekavana_pricina_deliria.php weekly 0.7 /artkey/far-202003-0003_lekove_problemy_v_teorii_a_prikladech_v_podminkach_ceske_republiky.php weekly 0.7 /artkey/far-202003-0004_klinicka_farmacie_v_geriatrii_a_20_let_klinickych_a_vyzkumnych_zkusenosti_s_hodnocenim_racionality_geriatricke.php weekly 0.7 /artkey/far-202003-0005_leky_indukovane_dysnatremie_i_polekove_hyponatremie.php weekly 0.7 /artkey/far-202003-0008_slovo_uvodem.php weekly 0.7 /artkey/far-202003-0009_klinicka_farmakologie_a_farmacie_c_3_2020.php weekly 0.7 /magno/far/2020/mn4.php weekly 0.7 /flashbook/far/2020/4.php monthly 0.2 /artkey/far-202004-0001_comparison_of_dos_and_windows_version_of_the_mwpharm_-_a_pharmacokinetic_software_for_pk_pd_monitoring_of_digox.php weekly 0.7 /artkey/far-202004-0006_pour_feliciter_2021.php weekly 0.7 /artkey/far-202004-0005_ceftazidim_avibaktam_v_terapii_infekcnich_komplikaci_kriticky_popaleneho_pacienta_s_inhalacnim_traumatem.php weekly 0.7 /artkey/far-202004-0002_specifika_metabolismu_leciv_v_detskem_veku.php weekly 0.7 /artkey/far-202004-0003_liraglutid_u_diabetikov_v_studii_leader_-_nachadzame_benefit_u_chorych_so_srdcovym_zlyhavanim.php weekly 0.7 /artkey/far-202004-0004_izotretinoin_v_liecbe_acne_vulgaris_-_uloha_alternativnych_davkovacich_rezimov.php weekly 0.7 /artkey/far-202004-0007_tribute_czech_clinical_pharmacology_folke_sj_qvist_8217_s_overall_importance_for_clinical_pharmacology.php weekly 0.7 /artkey/far-202004-0008_klinicka_farmakologie_a_farmacie_c_4_2020.php weekly 0.7 /magno/far/2019/mn1.php weekly 0.7 /flashbook/far/2019/1.php monthly 0.2 /artkey/far-201901-0002_prehled_poznatku_o_ucinnosti_intervenci_na_podporu_adherence_k_lecbe_u_pacientu_po_organovych_transplantacich.php weekly 0.7 /artkey/far-201901-0007_aktualni_farmakoterapie_virovych_hepatitid.php weekly 0.7 /artkey/far-201901-0008_hypnotika_v_lecbe_nespavosti.php weekly 0.7 /artkey/far-201901-0001_slovo_uvodem.php weekly 0.7 /artkey/far-201901-0009_uprava_davky_chemoterapie_u_pacienta_po_amputaci_horni_a_dolni_koncetiny.php weekly 0.7 /artkey/far-201901-0003_lecba_ocnich_projevu_imunitne_podminenych_zanetlivych_onemocneni.php weekly 0.7 /artkey/far-201901-0004_pouziti_anti_8209_vegf_leku_v_oftalmologii.php weekly 0.7 /artkey/far-201901-0005_prehled_ocnich_lekovych_forem.php weekly 0.7 /artkey/far-201901-0006_nezadouci_ucinky_antiglaukomatik_na_oko.php weekly 0.7 /artkey/far-201901-0010_klinicka_farmakologie_a_farmacie_c_1_2019.php weekly 0.7 /magno/far/2019/mn2.php weekly 0.7 /flashbook/far/2019/2.php monthly 0.2 /artkey/far-201902-0001_slovo_uvodem.php weekly 0.7 /artkey/far-201902-0002_mystery_shopping_a_vzdelavanie_studentov_farmacie_pri_dispenzacii_a_poradenstve_o_otc_lieku.php weekly 0.7 /artkey/far-201902-0007_farmakoterapie_epilepsii_z_pohledu_neurologa_epileptologa.php weekly 0.7 /artkey/far-201902-0008_lekove_interakce_casto_predepisovanych_antidepresiv.php weekly 0.7 /artkey/far-201902-0009_nexobridtm_novy_preparat_pro_enzymatickou_nekrolyzu_u_pacienta_s_termickym_traumatem.php weekly 0.7 /artkey/far-201902-0003_inhalacni_celkova_anestetika_a_jejich_pouziti.php weekly 0.7 /artkey/far-201902-0004_nitrozilni_anestetika.php weekly 0.7 /artkey/far-201902-0005_periferni_myorelaxancia_v_moderni_anesteziologii.php weekly 0.7 /artkey/far-201902-0006_perioperacni_lecba_bolesti.php weekly 0.7 /artkey/far-201902-0010_oborove_kongresy_pomahaji_v_regionu_stredni_evropy_zvysovat_povedomi_o_klinicke_farmacii.php weekly 0.7 /artkey/far-201902-0011_klinicka_farmakologie_a_farmacie_c_2_2019.php weekly 0.7 /magno/far/2019/mn3.php weekly 0.7 /flashbook/far/2019/3.php monthly 0.2 /artkey/far-201903-0002_targeting_asthma_control_in_real_8209_life_clinical_practice_by_using_ics_laba_combination.php weekly 0.7 /artkey/far-201903-0007_budouci_trendy_v_lecbe_karcinomu_jicnu_prevence_biologicka_terapie_imunoterapie_individualizovana_terapie.php weekly 0.7 /artkey/far-201903-0008_ceftolozan_tazobaktam_v_terapii_multifokalni_infekce_zpusobene_multirezistentnim_kmenem_pseudomonas_aeruginosa.php weekly 0.7 /artkey/far-201903-0009_metamizol_ovplyvnil_nastup_ucinku_filgrastimu.php weekly 0.7 /artkey/far-201903-0003_akutni_poskozeni_ledvin_asociovane_s_kontrastnimi_latkami_8211_up_to_date_2019.php weekly 0.7 /artkey/far-201903-0004_imunitne_podminene_nezadouci_ucinky_inhibitoru_kontrolnich_bodu.php weekly 0.7 /artkey/far-201903-0005_hypertenze_jako_nezadouci_ucinek_leciv.php weekly 0.7 /artkey/far-201903-0006_bezpecnost_lecby_roztrousene_sklerozy_z_dlouhodobeho_hlediska_ve_vztahu_k_teriflunomidu_a_alemtuzumabu.php weekly 0.7 /artkey/far-201903-0001_genericke_leky_teorie_a_praxe.php weekly 0.7 /artkey/far-201903-0010_klinicka_farmakologie_a_farmacie_c_3_2019.php weekly 0.7 /magno/far/2019/mn4.php weekly 0.7 /flashbook/far/2019/4.php monthly 0.2 /artkey/far-201904-0001_lekove_chyby_na_jednotkach_intenzivni_pece_znalosti_a_postoje_vseobecnych_sester.php weekly 0.7 /artkey/far-201904-0005_minimalizace_rizik_a_teorie_tri_piliru_u_leciv_zvysujicich_riziko_padu.php weekly 0.7 /artkey/far-201904-0006_inhibitory_angiotenzin_konvertujiciho_enzymu_v_nefrologii.php weekly 0.7 /artkey/far-201904-0007_prodlouzeni_infuze_oxacilinu_u_pacienta_se_stafylokokovou_bakteriemii.php weekly 0.7 /artkey/far-201904-0002_farmakoterapie_v_gravidite.php weekly 0.7 /artkey/far-201904-0003_terapeuticke_monitorovani_leciv_v_tehotenstvi.php weekly 0.7 /artkey/far-201904-0004_principy_farmakoterapie_pri_kojeni.php weekly 0.7 /artkey/far-201904-0008_klinicka_farmakologie_a_farmacie_c_4_2019.php weekly 0.7 /magno/far/2018/mn1.php weekly 0.7 /artkey/far-201801-0001_Prednisolon_jako_priklad_latky_vybrane_do_seznamu_Medical_Literature_Monitoring.php weekly 0.7 /artkey/far-201801-0007_Liecba_a_osetrovanie_vredu_predkolenia_pomocou_vlhkej_terapie.php weekly 0.7 /artkey/far-201801-0005_Blokatory_kalcioveho_kanalu_po_50_letech.php weekly 0.7 /artkey/far-201801-0006_Metformin_stara_latka_8211_nove_indikace.php weekly 0.7 /artkey/far-201801-0002_Nove_moznosti_lecby_anemie_u_nemocnych_s_chronickym_onemocnenim_ledvin.php weekly 0.7 /artkey/far-201801-0003_Polekove_poskozeni_ledvin.php weekly 0.7 /artkey/far-201801-0004_Renoprotektivni_ucinky_gliflozinu.php weekly 0.7 /magno/far/2018/mn2.php weekly 0.7 /artkey/far-201802-0001_Epidemiologicka_studie_novych_peroralnich_antikoagulancii.php weekly 0.7 /artkey/far-201802-0002_Misto_farmakoterapie_v_lecbe_myasthenia_gravis.php weekly 0.7 /artkey/far-201802-0003_Antiparkinsonika_psychicke_poruchy_u_pacientu_s_Parkinsonovou_nemoci_a_lekove_interakce.php weekly 0.7 /artkey/far-201802-0004_Malaria_jej_liecba_a_profylaxia.php weekly 0.7 /artkey/far-201802-0005_Lokalni_anestetika_z_pohledu_anesteziologa.php weekly 0.7 /artkey/far-201802-0006_Zivot_ohrozujici_hypoglykemie_u_detskeho_pacienta_s_infantilni_myofibromatozou_na_lecbe_sunitinibem.php weekly 0.7 /artkey/far-201802-0007_Doc_RNDr_Nina_Skottova_CSc.php weekly 0.7 /magno/far/2018/mn3.php weekly 0.7 /artkey/far-201803-0001_Stanoveni_obsahu_silybinu_v_potravnich_doplncich_obsahujicich_silymarin.php weekly 0.7 /artkey/far-201803-0005_Vybrana_biologicka_leciva_v_neonkologickych_indikacich.php weekly 0.7 /artkey/far-201803-0006_Lecba_bolesti_fixni_kombinaci_orfenadrinu_a_diklofenaku.php weekly 0.7 /artkey/far-201803-0007_Akutni_hepatotoxicita_po_intravenozni_aplikaci_amiodaronu.php weekly 0.7 /artkey/far-201803-0008_Problemy_alopecie_u_mladych_zien.php weekly 0.7 /artkey/far-201803-0002_Farmakoterapie_idiopatickych_strevnich_zanetu.php weekly 0.7 /artkey/far-201803-0003_Vedolizumab_jeho_farmakologicky_profil_a_lecebne_vyuziti.php weekly 0.7 /artkey/far-201803-0004_Novinky_v_systemove_lecbe_pokrocileho_a_metastatickeho_karcinomu_zaludku.php weekly 0.7 /artkey/far-201803-0009_Vzpominka_na_doc_MUDr_Otto_Mayera_CSc.php weekly 0.7 /magno/far/2018/mn4.php weekly 0.7 /artkey/far-201804-0001_Akademicke_klinicke_studie_v_Ceske_republice_8211_prehled_za_obdobi_2004_8211_2017.php weekly 0.7 /artkey/far-201804-0005_Konjugovane_monoklonalni_protilatky.php weekly 0.7 /artkey/far-201804-0006_Je_suplementace_kalciem_v_paliativni_peci_vzdy_zbytecna.php weekly 0.7 /artkey/far-201804-0002_Aktualni_farmakoterapie_tuberkulozy.php weekly 0.7 /artkey/far-201804-0003_Lecba_CHOPN.php weekly 0.7 /artkey/far-201804-0004_Polekove_poskozeni_plic.php weekly 0.7 /magno/far/2018/mn88.php weekly 0.7 /artkey/far-201888-0001_E-verze_1_18.php weekly 0.7 /magno/far/2018/mn89.php weekly 0.7 /artkey/far-201889-0001_E-verze_2_18.php weekly 0.7 /magno/far/2018/mn90.php weekly 0.7 /artkey/far-201890-0001_E-verze_3_18.php weekly 0.7 /magno/far/2018/mn91.php weekly 0.7 /artkey/far-201891-0001_E-verze_4_18.php weekly 0.7 /magno/far/2017/mn1.php weekly 0.7 /artkey/far-201701-0001_Lipegfilgrastim_efektivna_moznost_ako_sa_vyhnut_chemoterapiou_indukovanej_neutropenii.php weekly 0.7 /artkey/far-201701-0005_Protizapalova_liecba_stabilnej_CHOCHP_8211_aktualne_trendy_a_odporucania_pre_klinicku_praxExpertne_stanovisk.php weekly 0.7 /artkey/far-201701-0006_Secukinumab_v_terapii_psoriaticke_artritidy.php weekly 0.7 /artkey/far-201701-0007_Cilostazol_v_lecbe_ischemicke_choroby_dolnich_koncetin.php weekly 0.7 /artkey/far-201701-0008_Zkusenost_z_praxe_s_biologickou_lecbou_8222_jeden_a_pulte_8220_linie_u_pacientu_s_relaps-remitentni_roztrou.php weekly 0.7 /artkey/far-201701-0002_Nova_lecba_hepatitidy_C.php weekly 0.7 /artkey/far-201701-0003_Aktualni_pohled_na_epidemiologii_a_pristupyk_lecbe_virovych_hepatitid_A_a_E.php weekly 0.7 /artkey/far-201701-0004_Alveolarni_echinokokoza_8211_zivot_ohrozujicionemocneni.php weekly 0.7 /magno/far/2017/mn2.php weekly 0.7 /artkey/far-201702-0001_Neodolpasse_v_casnem_pooperacnim_obdobi_neovlivnuje_tvorbu_krevniho_koagula_8211_prospektivni_kohortove_sled.php weekly 0.7 /artkey/far-201702-0002_Lekove_interakce_makrolidu_v_roce_2017.php weekly 0.7 /artkey/far-201702-0003_Specifika_percepcie_rizika_liekov_u_zien.php weekly 0.7 /artkey/far-201702-0004_Zhodnoceni_ucinnosti_a_rizik_v_lecbe_roztrousene_sklerozy.php weekly 0.7 /artkey/far-201702-0005_Herpesviry_a_rezistence_k_antiviroticke_terapii.php weekly 0.7 /artkey/far-201702-0007_Apixaban_jiz_vice_nez_dva_roky_dostupny_v_lecbe_zilni_trombembolicke_nemoci.php weekly 0.7 /artkey/far-201702-0006_Nezadouci_ucinky_metoklopramidu_Degan_8211_z_pohledu_pacienta.php weekly 0.7 /magno/far/2017/mn3.php weekly 0.7 /artkey/far-201703-0001_Possible_interaction_between_mycophenolatemofetil_and_tacrolimus_in_kidney_transplant_patients.php weekly 0.7 /artkey/far-201703-0002_Muze_byt_pregabalin_efektivni_u_lecby_deprese.php weekly 0.7 /artkey/far-201703-0003_Dlouhodobe_pusobici_antipsychotika_v_praxi.php weekly 0.7 /artkey/far-201703-0004_Suplementace_horciku_8211_farmakologickemechanismy_metody_podani_a_pasti.php weekly 0.7 /artkey/far-201703-0005_Antiresorpcne_latky_a_osteonekroza_celustiz_pohladu_stomatologie.php weekly 0.7 /artkey/far-201703-0006_Intratekalni_podani_leciv_u_onkologickehopacienta_s_refrakterni_bolesti.php weekly 0.7 /artkey/far-201703-0007_Evolokumab_pro_lecbu_familiarnihypercholesterolemie.php weekly 0.7 /artkey/far-201703-0009_Odefsey_a_jeho_soucasna_pozice_v_lecbe_HIV_infekce.php weekly 0.7 /artkey/far-201703-0008_Zemrel_prof_MUDr_Karel_Trnavsky_DrSc.php weekly 0.7 /magno/far/2017/mn4.php weekly 0.7 /artkey/far-201704-0001_Co_prinasi_a_co_neprinasi_Evropska_lekova_agentura_ve_sluzbe_Medical_Literature_Monitoring_z_pohledu_ceske_fa.php weekly 0.7 /artkey/far-201704-0006_Neod_vodnene_prerusenie_preventivnej_terapie_statinmi_8211_klinicke_d_sledky.php weekly 0.7 /artkey/far-201704-0007_Hyperlipidemia_vyvolana_quetiapinom_sp_sobujuca_akutnu_pankreatitidu.php weekly 0.7 /artkey/far-201704-0002_Uvodni_slovo.php weekly 0.7 /artkey/far-201704-0003_Profylaxe_tromboz_po_ortopedickych_operacich.php weekly 0.7 /artkey/far-201704-0004_Aktualni_postaveni_peroralnich_chrupavkuovlivnujicich_latek_v_prevenci_a_terapii_kloubnichnemoci.php weekly 0.7 /artkey/far-201704-0005_Antibiotika_v_kostnim_cementu.php weekly 0.7 /magno/far/2017/mn88.php weekly 0.7 /artkey/far-201788-0001_E-verze_1_17.php weekly 0.7 /magno/far/2017/mn89.php weekly 0.7 /artkey/far-201789-0001_E-verze_2_17.php weekly 0.7 /magno/far/2017/mn90.php weekly 0.7 /artkey/far-201790-0001_E-verze_3_17.php weekly 0.7 /magno/far/2017/mn91.php weekly 0.7 /artkey/far-201791-0001_E-verze_4_17.php weekly 0.7 /magno/far/2016/mn1.php weekly 0.7 /artkey/far-201601-0002_Uzivani_pripravku_ze_zlatobylu_obecneho_Solidago_virgaurea_neovlivnuje_metabolizmus_soucasne_poda.php weekly 0.7 /artkey/far-201601-0003_Uzivanie_postoje_a_znalosti_laickej_verejnosti_na_Slovensku_o_vyzivovych_doplnkoch.php weekly 0.7 /artkey/far-201601-0008_Stribild_a_jeho_soucasna_pozice_v_lecbe_HIV_infekce.php weekly 0.7 /artkey/far-201601-0009_Antifosfolipidovy_syndrom_a_tromboza.php weekly 0.7 /artkey/far-201601-0004_Klinicky_relevantne_otazky_a_aktualne_trendy_vo_farmakoterapii_chronickej_obstrukcnej_choroby_pluc.php weekly 0.7 /artkey/far-201601-0005_Klinicky_relevantne_otazky_a_aktualne_trendy_vo_farmakoterapii_chronickej_obstrukcnej_choroby_pluc.php weekly 0.7 /artkey/far-201601-0006_Aktualni_farmakoterapie_idiopaticke_plicni_fibrozy.php weekly 0.7 /artkey/far-201601-0007_Akutni_bronchitis_a_pneumonie_v_klinicke_praxi.php weekly 0.7 /artkey/far-201601-0001_Clinical_Pharmacology_and_how_to_use_successful_drugs_even_better.php weekly 0.7 /magno/far/2016/mn2.php weekly 0.7 /artkey/far-201602-0001_Slovo_uvodem.php weekly 0.7 /artkey/far-201602-0002_Terapeuticke_monitorovani_vankomycinu_v_klinicke_praxi.php weekly 0.7 /artkey/far-201602-0006_Vitamin_D_a_roztrousena_skleroza.php weekly 0.7 /artkey/far-201602-0007_Symptomaticka_lecba_dnave_artritidy.php weekly 0.7 /artkey/far-201602-0008_Hypolipidemika_a_ich_vplyv_na_funkciu_endotelu_prehlad_vysledkov_klinickych_studii.php weekly 0.7 /artkey/far-201602-0009_Zmena_barvy_kuze_jako_nezadouci_ucinek_pri_lecbe_sunitinibem_u_detske_pacientky_s_osteosarkomem.php weekly 0.7 /artkey/far-201602-0003_Terapeuticke_monitorovani_hladin_antiepileptik_I-obecne_zasady_8222_stara_8220_antiepilepti.php weekly 0.7 /artkey/far-201602-0004_Terapeuticke_monitorovani_hladin_antiepileptik_II-8222_nova_8220_antiepileptika_specialni_s.php weekly 0.7 /artkey/far-201602-0005_Trend_analysis_of_the_utilization_of_antiepileptic_drugs_in_pregnant_women_with_epilepsy_in_Moravia.php weekly 0.7 /magno/far/2016/mn3.php weekly 0.7 /artkey/far-201603-0001_Monitoring_of_the_serum_biomarkers_during_the_therapy_period_of_the_patients_with_rheumatoid_arthritis_Pilot_S.php weekly 0.7 /artkey/far-201603-0002_Ibrutinib_v_hematoonkologii.php weekly 0.7 /artkey/far-201603-0003_Dabigatran_-_klinicke_dukazy_pro_lecbu_pacientu_s_TEN.php weekly 0.7 /artkey/far-201603-0004_Koloidni_stribro_a_jeho_biologicka_aktivita.php weekly 0.7 /artkey/far-201603-0005_Lecba_neuropaticke_bolesti_se_zamerenim_na_opioidy.php weekly 0.7 /artkey/far-201603-0006_Nova_antibiotika_v_klinicke_praxi_a_vyzkumu.php weekly 0.7 /artkey/far-201603-0007_Sepse_z_pohledu_klinicke_mikrobiologie.php weekly 0.7 /artkey/far-201603-0008_Amiodaron_dobry_sluha_zly_pan_Kazuistika_amiodaronem_indukovane_tyreotoxikozy_s_fatalnim_koncem.php weekly 0.7 /magno/far/2016/mn4.php weekly 0.7 /artkey/far-201604-0001_Vyhodnoceni_dotazu_na_lekove_interakce_v_internetove_poradne_8222_Znam_sve_leky_8220.php weekly 0.7 /artkey/far-201604-0004_Lekove_interakce_antiepileptik_Cast_1_8211_vzajemne_interakce_mezi_antiepileptiky.php weekly 0.7 /artkey/far-201604-0005_Soucasny_pohled_na_roli_inhibitoru_TNF_945_v_terapii_pacientu_s_toxickou_epidermalni_nekrolyzou.php weekly 0.7 /artkey/far-201604-0006_Karcinom_prsu_chronicke_onemocneni_8211_Anti_HER2_terapie.php weekly 0.7 /artkey/far-201604-0002_Monoklonalni_protilatky_v_terapii_vysokych_hladin_cholesterolu.php weekly 0.7 /artkey/far-201604-0003_Vyhodnoceni_ucinnosti_lecby_anti-IgE_monoklonalni_protilatkou_nejen_u_tezkeho_alergickeho_astmatu.php weekly 0.7 /magno/far/2016/mn88.php weekly 0.7 /artkey/far-201688-0001_E-verze_1_16.php weekly 0.7 /magno/far/2016/mn89.php weekly 0.7 /artkey/far-201689-0001_E-verze_2_16.php weekly 0.7 /magno/far/2016/mn90.php weekly 0.7 /artkey/far-201690-0001_E-verze_3_16.php weekly 0.7 /magno/far/2016/mn91.php weekly 0.7 /artkey/far-201691-0001_E-verze_4_16.php weekly 0.7 /magno/far/2015/mn1.php weekly 0.7 /artkey/far-201501-0001_Slovo_uvodem.php weekly 0.7 /artkey/far-201501-0002_Spotreba_antibiotik_a_antimykotik_u_tezce_popalenych_pacientu_vyzadujicich_intenzivni_peci.php weekly 0.7 /artkey/far-201501-0009_Novinky_v_lecbe_sucheho_oka.php weekly 0.7 /artkey/far-201501-0010_Fixni_kombinace_Cyclo_3_Fort_v_lecbe_CVI.php weekly 0.7 /artkey/far-201501-0003_Prehled_biologicke_lecby_HER2-pozitivniho_metastatickeho_karcinomu_prsu.php weekly 0.7 /artkey/far-201501-0004_Farmakoterapie_pokrocileho_ci_metastazujiciho_nadoru_mocoveho_mechyre.php weekly 0.7 /artkey/far-201501-0005_Lecba_pokrocileho_nemalobunecneho_plicniho_karcinomu.php weekly 0.7 /artkey/far-201501-0006_Jak_zmeni_nova_farmaka_lecbu_diabetu.php weekly 0.7 /artkey/far-201501-0007_Moznosti_farmakoterapie_v_lecbe_pacientu_se_syndromem_diabeticke_nohy.php weekly 0.7 /artkey/far-201501-0008_Moznosti_terapie_inzulinem_v_roce_2015.php weekly 0.7 /magno/far/2015/mn2.php weekly 0.7 /artkey/far-201502-0001_Vyvoj_rezistence_invazivnich_bakterii_v_souvislosti_se_spotrebou_antibiotik.php weekly 0.7 /artkey/far-201502-0002_Vliv_cyklosporinu_A_a_jeho_primarnich_metabolitu_na_cirkadialni_kolisani_krevniho_tlaku.php weekly 0.7 /artkey/far-201502-0007_Lecba_astmatu_2015.php weekly 0.7 /artkey/far-201502-0008_Inzulinova_analoga-zaklad_moderni_lecby_diabetu_1_i_2_typu.php weekly 0.7 /artkey/far-201502-0009_Vyhody_transdermalnich_forem_HRT_z_pohledu_gynekologa.php weekly 0.7 /artkey/far-201502-0010_Soucasne_uplatneni_rituximabu_ve_farmakoterapii.php weekly 0.7 /artkey/far-201502-0003_Nova_lecba_symptomatickeho_metastazujicicho_bazocelularniho_karcinomu_ci_lokalne_pokrocileho_ktery.php weekly 0.7 /artkey/far-201502-0004_Lecba_nejcastejsich_herpetickych_infekci_a_moznost_prevence_herpes_zoster.php weekly 0.7 /artkey/far-201502-0005_Maligni_melanom_s_BRAF_mutaci_a_moznosti_jeho_lecby.php weekly 0.7 /artkey/far-201502-0006_Etiopatogeneze_a_terapie_acne_vulgaris.php weekly 0.7 /magno/far/2015/mn3.php weekly 0.7 /artkey/far-201503-0002_Slovo_uvodem.php weekly 0.7 /artkey/far-201503-0008_Klinicke_vyuzitie_probiotik_v_prevencii_a_liecbe_poruch_traviaceho_traktu.php weekly 0.7 /artkey/far-201503-0009_Dimethyl-fumarat_v_lecbe_relabujici-remitujici_formy_roztrousene_sklerozy.php weekly 0.7 /artkey/far-201503-0010_Biosimilars_v_terapii_zanetlivych_revmatickych_onemocneni.php weekly 0.7 /artkey/far-201503-0011_Peritonealni_dialyza.php weekly 0.7 /artkey/far-201503-0001_Slovo_uvodem.php weekly 0.7 /artkey/far-201503-0003_Jake_mame_v_soucasne_dobe_moznosti_ovlivneni_imunity_v_bezne_klinicke_praxi.php weekly 0.7 /artkey/far-201503-0004_Moderni_antihistaminika_v_lecbe_alergie-soucasne_trendy_v_symptomaticke_terapii_alergickych_onemo.php weekly 0.7 /artkey/far-201503-0005_Inhalacni_kortikosteroidy_v_lecbe_bronchialniho_astmatu-mame_se_jich_bat_nebo_byt_radi_za_jejich.php weekly 0.7 /artkey/far-201503-0006_Biologicky_aktivne_fosfolipidy_izolovane_z_vajecneho_z_tka_zvysuju_cytotoxicky_ucinok_temozolomidu.php weekly 0.7 /artkey/far-201503-0012_Ohlednuti_za_letosnimi_mezinarodnimi_kongresy_klinicke_farmakologie.php weekly 0.7 /artkey/far-201503-0013_7_cesko-slovenska_konference_Klinicke_farmakologie-Olomouc_11_-12_zari_2015.php weekly 0.7 /artkey/far-201503-0007_Proc_inzulinovy_analog_lispro_v_koncentraci_200_U_ml.php weekly 0.7 /magno/far/2015/mn4.php weekly 0.7 /artkey/far-201504-0006_Uzivanie_postoje_a_znalosti_laickej_verejnosti_na_Slovensku_o_vyzivovych_doplnkoch.php weekly 0.7 /artkey/far-201504-0004_Mala_by_sa_dualna_bronchodilatacna_liecba_stat_prvou_volbou_vo_farmakoterapii_chronickej_obstrukcne.php weekly 0.7 /artkey/far-201504-0005_Odhadovana_glomerularni_filtrace_dospelych_pacientu.php weekly 0.7 /artkey/far-201504-0001_Slovo_uvodem.php weekly 0.7 /artkey/far-201504-0002_Prima_peroralni_antikoagulancia.php weekly 0.7 /artkey/far-201504-0003_8222_Prima_peroralni_antikoagulancia_8220_v_lecbe_zilni_trombembolicke_nemoci.php weekly 0.7 /magno/far/2014/mn1.php weekly 0.7 /artkey/far-201401-0001_Slovo_uvodem.php weekly 0.7 /artkey/far-201401-0003_Vliv_intervence_VZP_CR_na_preskripci_potencialnich_lekovych_interakci_lekari_Kralovehradeckeho_a_St.php weekly 0.7 /artkey/far-201401-0007_Vliv_infuzniho_systemu_na_kvalitu_parenteralni_lecby.php weekly 0.7 /artkey/far-201401-0008_Kortikorezistentni_astma-aktualni_klasifikace_definice_a_molekularni_mechanizmy_glukokortikoidni.php weekly 0.7 /artkey/far-201401-0004_Biosimilars-specifika_schvalovaciho_procesu_v_EU.php weekly 0.7 /artkey/far-201401-0005_Prvni_biosimilarni_monoklonalni_protilatka-infliximab.php weekly 0.7 /artkey/far-201401-0006_Farmakoekonomika_biologicke_lecby_ve_svetle_8222_biosimilars_8220.php weekly 0.7 /artkey/far-201401-0002_Quo_vadis_pharma_industry.php weekly 0.7 /artkey/far-201401-0009_Biosimilars-sance_pro_usporu_penez_v_evropskych_zdravotnich_systemech.php weekly 0.7 /artkey/far-201401-0010_Ucinnost_a_bezpecnost_pripravku_Zarzio_174_potvrzuji_vysledky_klinickych_studii_i_prakticke_zkuse.php weekly 0.7 /magno/far/2014/mn2.php weekly 0.7 /artkey/far-201402-0001_Slovo_uvodem.php weekly 0.7 /artkey/far-201402-0002_Pentoxifylin_v_lecbe_symptomaticke_ischemicke_choroby_tepen_dolnich_koncetin.php weekly 0.7 /artkey/far-201402-0003_CAM_Attitudes_Self-reported_Use_and_Client_Recommendations_of_Czech_Pharmacists_and_Pharmacy_Techn.php weekly 0.7 /artkey/far-201402-0004_Terapeuticke_monitorovanie_hladin_ako_sucast_optimalizacie_davkovacich_rezimov_gentamicinu_u_pacien.php weekly 0.7 /artkey/far-201402-0007_Postaveni_leflunomidu_v_lecbe_aktivni_revmatoidni_artritidy.php weekly 0.7 /artkey/far-201402-0008_Etravirin_v_klinicke_praxi.php weekly 0.7 /artkey/far-201402-0009_Moderni_technologie_a_zpusob_jejich_vyuzivani_pro_optimalizaci_lecby_diabetu_1_i_2_typu_v_praxi.php weekly 0.7 /artkey/far-201402-0010_Otrava_rtuti_jako_vyusteni_neobvykle_symptomatologie.php weekly 0.7 /artkey/far-201402-0005_Karcinom_prsu_v_tehotenstvi_a_v_obdobi_kojeni.php weekly 0.7 /artkey/far-201402-0006_Anestezie_u_operaci_v_tehotenstvi.php weekly 0.7 /magno/far/2014/mn3.php weekly 0.7 /artkey/far-201403-0001_Slovo_uvodem.php weekly 0.7 /artkey/far-201403-0002_Analyza_problematiky_vakcinacie_v_pediatrii.php weekly 0.7 /artkey/far-201403-0003_Spotreba_aspirinu_v_novom_tisicroci.php weekly 0.7 /artkey/far-201403-0007_Lecivy_indukovane_periferni_neuropatie.php weekly 0.7 /artkey/far-201403-0008_Novinky_v_protidestickove_lecbe_akutnich_koronarnich_syndromu.php weekly 0.7 /artkey/far-201403-0009_Prakticke_aspekty_hormonalni_lecby_karcinomu_prsu.php weekly 0.7 /artkey/far-201403-0010_Akutni_uzaver_abdominalni_aorty_jako_manifestace_heparinem_indukovane_trombocytopenie.php weekly 0.7 /artkey/far-201403-0004_Soucasne_moznosti_lecby_postmenopauzalni_osteoporozy.php weekly 0.7 /artkey/far-201403-0005_Zasadni_role_vitaminu_D_v_lecbe_osteoporozy.php weekly 0.7 /artkey/far-201403-0006_Vyvoj_novych_leciv_v_terapii_osteoporozy.php weekly 0.7 /artkey/far-201403-0011_Reakce_na_clanek_8222_Vliv_infuzniho_systemu_na_kvalitu_parenteralni_lecby_8220_autora_Karla_Ur.php weekly 0.7 /artkey/far-201403-0012_Doc_MUDr_Milan_Grundmann_CSc-75lety.php weekly 0.7 /magno/far/2014/mn4.php weekly 0.7 /artkey/far-201404-0001_Vzdelavani_lekaru-vcera-dnes-zitra.php weekly 0.7 /artkey/far-201404-0002_Vyuka_farmakologie_ve_vysokoskolskem_kvalifikacnim_vzdelavani_vseobecnych_sester_v_Ceske_republice.php weekly 0.7 /artkey/far-201404-0006_Efekt_revizi_farmakoterapie_na_mortalitu_a_hospitalizace_u_klientu_domu_s_pecovatelskou_sluzbou_vy.php weekly 0.7 /artkey/far-201404-0003_Cytochromy_P450_Role_v_metabolizmu_cholesterolu.php weekly 0.7 /artkey/far-201404-0004_Vakcinacia_a_prevencia_pneumokokovej_komunitnej_pneumonie.php weekly 0.7 /artkey/far-201404-0007_Kokrystal_ako_nova_forma_ochrany_dusevneho_vlastnictva.php weekly 0.7 /artkey/far-201404-0005_DRESS_syndrom_vznikly_pri_lecbe_alopurinolem.php weekly 0.7 /magno/far/2013/mn1.php weekly 0.7 /artkey/far-201301-0002_Hodnotenie_zivotneho_stylu_laickej_verejnosti_vo_vztahu_ku_kardiometabolickemu_riziku_pri_metabolic.php weekly 0.7 /artkey/far-201301-0006_Roflumilast_a_CHOPN.php weekly 0.7 /artkey/far-201301-0007_Lekove_chyby_v_osetrovatelstvi.php weekly 0.7 /artkey/far-201301-0008_Toxicita_barviv_pouzivanych_v_lecivych_pripravcich.php weekly 0.7 /artkey/far-201301-0001_Slovo_uvodem.php weekly 0.7 /artkey/far-201301-0009_Uspesne_zhojeni_akralniho_defektu_prstu_pri_lecbe_bosentanem_u_nemocne_se_smisenym_onemocnenim_poji.php weekly 0.7 /artkey/far-201301-0003_Antikoagulacna_terapia_u_geriatrickych_pacientov_s_fibrilaciou_predsieni.php weekly 0.7 /artkey/far-201301-0005_Expertni_konsenzus_CR_2012_v_oblasti_leciv.php weekly 0.7 /magno/far/2013/mn2.php weekly 0.7 /artkey/far-201302-0001_Vazene_damy_a_panove_kolegove_a_kolegyne.php weekly 0.7 /artkey/far-201302-0002_Ako_je_to_s_vnimanim_mozneho_rizika_lieku_u_pacientov_uzivajucich_nesteroidove_antiflogistika-analg.php weekly 0.7 /artkey/far-201302-0006_Strategie_hodnotenia_rizika_biologickych_liekov_s_aspektom_na_reumatoidnu_artritidu.php weekly 0.7 /artkey/far-201302-0007_Farmakologie_golimumabu_a_jeho_vyuziti_v_lecbe_pacientu_s_revmatoidni_artritidou.php weekly 0.7 /artkey/far-201302-0008_Indocyaninova_zelen-vlastnosti_soucasne_moznosti_a_trendy_vyuziti_v_klinickych_aplikacich.php weekly 0.7 /artkey/far-201302-0009_Papulopustulozni_exantem_jako_nezadouci_ucinek_cetuximabu.php weekly 0.7 /artkey/far-201302-0003_Problematika_sucheho_oka.php weekly 0.7 /artkey/far-201302-0004_Vekem_podminena_makularni_degenerace.php weekly 0.7 /artkey/far-201302-0005_Opticka_neuritida_a_roztrousena_skleroza.php weekly 0.7 /magno/far/2013/mn3.php weekly 0.7 /artkey/far-201303-0002_Vliv_rezistence_Pseudomonas_aeruginosa_na_antibioterapii.php weekly 0.7 /artkey/far-201303-0003_Compliance_pacientu_lecenych_interferony_pro_sclerosis_multiplex.php weekly 0.7 /artkey/far-201303-0007_Vybrane_atributy_v_liecbe_pooperacnej_bolesti_u_deti.php weekly 0.7 /artkey/far-201303-0008_Nove_poznatky_o_uloze_calcium-sensing_receptoru_pri_lecbe_poruch_kostni_a_mineralove_homeostazy.php weekly 0.7 /artkey/far-201303-0009_Farmakogenetika_metotrexatu_v_lecbe_revmatoidni_artritidy.php weekly 0.7 /artkey/far-201303-0001_Slovo_uvodem.php weekly 0.7 /artkey/far-201303-0004_Hypolipidemika_a_jejich_indikace_u_nemocnych_s_chronickym_onemocnenim_ledvin.php weekly 0.7 /artkey/far-201303-0005_Perspektivy_dalsiho_snizovani_cholesterolu_pomoci_blokady_PCSK9.php weekly 0.7 /artkey/far-201303-0006_Soucasne_postaveni_fibratu_v_lecbe_dyslipidemie_u_nemocnych_s_kardiometabolickym_syndromem.php weekly 0.7 /artkey/far-201303-0010_Pouziti_ertapenemu_v_terapii_gynekologickych_a_urologickych_infekci.php weekly 0.7 /magno/far/2012/mn1.php weekly 0.7 /artkey/far-201201-0001_Ceska_neuropsychofarmakologicka_spolecnost_slavi_55_vyroci.php weekly 0.7 /artkey/far-201201-0002_Volba_antihypertenznej_liecby_u_hospitalizovanych_geriatrickych_pacientov.php weekly 0.7 /artkey/far-201201-0003_Porovnanie_trendov_v_spotrebe_opioidov_SR_a_CR.php weekly 0.7 /artkey/far-201201-0007_Inkretinova_lecba_a_riziko_akutni_pankreatitidy.php weekly 0.7 /artkey/far-201201-0008_Aktualni_lecba_peroralnimi_antidiabetiky.php weekly 0.7 /artkey/far-201201-0009_Studie_MOTUDI-ovlivneni_hmotnosti_inzulinovou_lecbou_u_nemocnych_s_DM2_v_CR_Jindriska_Perusicova.php weekly 0.7 /artkey/far-201201-0004_Psychofarmakologie_je_uz_sedesatileta.php weekly 0.7 /artkey/far-201201-0005_Aktualizovane_klinicke_a_teoreticke_aspekty_podavani_antipsychotik.php weekly 0.7 /artkey/far-201201-0006_Antidepresiva-od_teorie_ke_klinicke_praxi.php weekly 0.7 /magno/far/2012/mn2.php weekly 0.7 /artkey/far-201202-0001_Slovo_uvodem.php weekly 0.7 /artkey/far-201202-0002_Rezistence_enterobakterii_k_vybranym_antibiotikum_v_souvislosti_s_jejich_spotrebou.php weekly 0.7 /artkey/far-201202-0003_Preskripcia_antiagregacnej_liecby_u_starsich_pacientov_s_aterosklerotickym_ochorenim_koronarnych_a.php weekly 0.7 /artkey/far-201202-0008_Intoxikace_venlafaxinem-vyuziti_TDM_fenotypizace_a_genotypizace.php weekly 0.7 /artkey/far-201202-0009_Analgetika_dennej_potreby_ich_rizika_a_perspektiva_vyvoja.php weekly 0.7 /artkey/far-201202-0010_Optimalizacia_davkovacich_rezimov_gentamicinu_u_specifickych_skupin_pacientov_a_informacie_o_lieku.php weekly 0.7 /artkey/far-201202-0011_Novinky_v_terapii_bolesti.php weekly 0.7 /artkey/far-201202-0004_Venous_thromboembolism_in_patients_with_special_conditions-editorial.php weekly 0.7 /artkey/far-201202-0005_Porovnani_warfarinu_a_novych_antitrombotik_z_hlediska_lekovych_interakci.php weekly 0.7 /artkey/far-201202-0006_Protidestickova_terapie.php weekly 0.7 /artkey/far-201202-0007_Krvacive_komplikace_a_predavkovani_antikoagulacni_lecby.php weekly 0.7 /artkey/far-201202-0012_Vitame_nove_cleny_casopisu_redakcni_rady.php weekly 0.7 /magno/far/2012/mn3.php weekly 0.7 /artkey/far-201203-0002_Postoje_a_adherence_diabetiku_2_typu_k_farmakologicke_lecbe-pilotni_projekt.php weekly 0.7 /artkey/far-201203-0003_Analyza_role_farmaceuta_pri_poskytovani_konzultaci_pacientum_s_rizikem_nadvahy_nebo_obezity_v_lekar.php weekly 0.7 /artkey/far-201203-0010_Redukce_telesne_hmotnosti_u_obezni_zeny_s_prediabetem_pri_dvoulete_lecbe_liraglutidem_a_metforminem.php weekly 0.7 /artkey/far-201203-0008_Farmakokinetika_rivaroxabanu.php weekly 0.7 /artkey/far-201203-0009_Inkretiny_inhibitory_DPP4_a_inhibitory_SGLT2_Nedavne_novinky_a_soucasne_perspektivy_etiopatogeneti.php weekly 0.7 /artkey/far-201203-0001_Personalizovana_medicina_farmakogenetika-nadeje_nebo_bublina.php weekly 0.7 /artkey/far-201203-0011_Barviva_a_jejich_vliv_na_lidsky_organizmus.php weekly 0.7 /artkey/far-201203-0004_Personalizovana_medicina.php weekly 0.7 /artkey/far-201203-0005_Perzonalizovana_medicina-soucasna_praxe_a_prisliby_do_budoucna.php weekly 0.7 /artkey/far-201203-0006_Farmakogenomika-soucasnost_budoucnost_perspektiva.php weekly 0.7 /artkey/far-201203-0007_Obecne_zasady_terapeutickeho_monitorovani_hladin_psychofarmak.php weekly 0.7 /artkey/far-201203-0012_Druhy_rocnik_mezioboroveho_seminare_mladych_farmakologu_a_toxikologu-KVETINUV_DEN.php weekly 0.7 /magno/far/2012/mn4.php weekly 0.7 /artkey/far-201204-0002_Vyskyt_off-label_a_unlicensed_preskripce_u_deti.php weekly 0.7 /artkey/far-201204-0010_Gratulujeme_8230.php weekly 0.7 /artkey/far-201204-0005_Respiracni_syncytialni_virus-moznosti_prevence_a_lecby.php weekly 0.7 /artkey/far-201204-0006_Personalizovana_medicina_a_biomarkery_v_onkologii.php weekly 0.7 /artkey/far-201204-0007_Farmakogenetika_a_polekove_reakce_z_precitlivelosti.php weekly 0.7 /artkey/far-201204-0001_Slovo_uvodem.php weekly 0.7 /artkey/far-201204-0009_Pantoprazol_pro_parenteralni_podani.php weekly 0.7 /artkey/far-201204-0008_Pouziti_bosentanu_v_lecbe_vaskularnich_komplikaci_systemove_sklerodermie.php weekly 0.7 /artkey/far-201204-0003_Poliekove_poskodenie_obliciek_s_aspektom_na_nesteroidove_antiflogistika.php weekly 0.7 /artkey/far-201204-0004_Bardoxolon-lze_glomerularni_filtraci_dlouhodobe_bezpecne_zvysit_i_u_pacientu_s_pokrocilou_renalni.php weekly 0.7 /magno/far/2011/mn1.php weekly 0.7 /artkey/far-201101-0003_Klinicky_efekt_cyklosporinu_u_nemocnych_s_revmatoidni_artritidou_a_dalsimi_revmatologickymi_choro.php weekly 0.7 /artkey/far-201101-0004_Porovnani_originalnich_a_generickych_pripravku_karbapenemovych_antibiotik.php weekly 0.7 /artkey/far-201101-0008_Novy_lek_v_symptomaticke_terapii_roztrousene_sklerozy_mozkomisni_4-aminopyridin_FAMPRIDINE-SR.php weekly 0.7 /artkey/far-201101-0009_Peroralne_antidiabetika_a_ich_vplyv_na_endotelovu_dysfunkciu.php weekly 0.7 /artkey/far-201101-0010_Lecba_migreny_behem_gravidity.php weekly 0.7 /artkey/far-201101-0002_Klinicka_farmakologie_a_farmacie-25_rocnik.php weekly 0.7 /artkey/far-201101-0005_Lecba_rustovym_hormonem_v_pediatrii_Historie_a_soucasnost.php weekly 0.7 /artkey/far-201101-0006_Subklinicke_tyreopatie.php weekly 0.7 /artkey/far-201101-0007_Uzel_stitne_zlazy.php weekly 0.7 /artkey/far-201101-0001_Endokrinologie_obor_zabyvajici_se_zasadnimi_aspekty_humoralnich_regulaci_v_organizmu.php weekly 0.7 /artkey/far-201101-0011_Laudatio_prof_MUDr_Milan_Kriska_DrSc.php weekly 0.7 /artkey/far-201101-0012_Sedmdesatiny_doc_MUDr_Otto_Mayera_CSc.php weekly 0.7 /magno/far/2011/mn2.php weekly 0.7 /artkey/far-201102-0001_Slovo_uvodem.php weekly 0.7 /artkey/far-201102-0002_Predpis_antimikrobialnich_pripravku_pacientum_na_chronicke_imunosupresivni_lecbe.php weekly 0.7 /artkey/far-201102-0003_Bezpecnost_antiepileptik_a_jej_vztah_ku_kvalite_zivota_detskych_pacientov_s_epilepsiou.php weekly 0.7 /artkey/far-201102-0008_Lecba_periferni_neuropaticke_bolesti.php weekly 0.7 /artkey/far-201102-0009_Poznamky_k_inovacim_v_cytostaticke_terapii_5-fluorouracilem.php weekly 0.7 /artkey/far-201102-0010_Krvaceni_do_traviciho_traktu_v_dusledku_lekove_interakce_warfarinu_s_ciprofloxacinem.php weekly 0.7 /artkey/far-201102-0004_Soucasny_prehled_moznosti_v_antiresorpcni_lecbe.php weekly 0.7 /artkey/far-201102-0005_Vitamin_D.php weekly 0.7 /artkey/far-201102-0006_Certolizumab_a_lecba_revmatoidni_artritidy.php weekly 0.7 /artkey/far-201102-0007_Tocilizumab-prinos_blokady_interleukinu_6.php weekly 0.7 /magno/far/2011/mn3.php weekly 0.7 /artkey/far-201103-0002_Nezadouci_ucinky_leku_v_casopise_Klinicka_farmakologie_a_farmacie.php weekly 0.7 /artkey/far-201103-0001_Snasenlivost_cyklosporinu_A_u_nemocnych_s_revmatoidni_artritidou_a_dalsimi_revmatologickymi_choroba.php weekly 0.7 /artkey/far-201103-0004_Davkovani_vankomycinu_pri_kontinualni_nahrade_funkce_ledvin.php weekly 0.7 /artkey/far-201103-0009_Probiotika_v_lecbe_jaternich_chorob.php weekly 0.7 /artkey/far-201103-0010_Ertapenem_a_jeho_postaveni_mezi_ostatnimi_karbapenemy.php weekly 0.7 /artkey/far-201103-0011_Porucha_prijmu_potravy_u_mladeho_hypertonika_a_kompenzace_hypertenze.php weekly 0.7 /artkey/far-201103-0005_Hodnotenie_rizika_liekov-vyvoj_terminologie.php weekly 0.7 /artkey/far-201103-0006_Anticholinergicke_ucinky_lieciv_u_starsich_pacientov.php weekly 0.7 /artkey/far-201103-0007_Kardiovaskularne_riziko_nesteroidovych_antiflogistik-klinicky_dopad_a_mozne_mechanizmy.php weekly 0.7 /artkey/far-201103-0008_Nezadouci_ucinky_leku_specificke_pro_detsky_vek.php weekly 0.7 /artkey/far-201103-0003_Pharmacovigilance_in_a_changing_world.php weekly 0.7 /artkey/far-201103-0012_Zprava_z_konference.php weekly 0.7 /artkey/far-201103-0013_Klinicka_farmakologie_na_Malte_se_predstavuje.php weekly 0.7 /magno/far/2011/mn4.php weekly 0.7 /artkey/far-201104-0002_Vztah_mezi_kinetickymi_parametry_5-fluorouracilu_a_odpovedi_na_neoadjuvantni_chemoradioterapii_loka.php weekly 0.7 /artkey/far-201104-0003_Potencialne_nevhodna_preskripcia_u_starsich_pacientov_porovnanie_vybranych_indikatorov_kvality.php weekly 0.7 /artkey/far-201104-0007_Lekove_interakce_inhibitoru_protonove_pumpy.php weekly 0.7 /artkey/far-201104-0001_Soucasny_pohled_na_problematiku_alergickych_onemocneni.php weekly 0.7 /artkey/far-201104-0008_Nezadouci_ucinek_blokatoru_kalciovych_kanalu-otok_dolnich_koncetin.php weekly 0.7 /artkey/far-201104-0009_Anafylaxe_po_poziti_kminu.php weekly 0.7 /artkey/far-201104-0004_Soucasny_pohled_na_terapii_anafylaxe.php weekly 0.7 /artkey/far-201104-0005_Alergicka_ryma-klinicke_aspekty_a_lecba.php weekly 0.7 /artkey/far-201104-0006_Farmakoterapie_pruduskoveho_astmatu.php weekly 0.7 /artkey/far-201104-0010_Komentar_k_clanku_Hodnotenie_rizika_liekov-vyvoj_terminologie.php weekly 0.7 /magno/far/2010/mn1.php weekly 0.7 /artkey/far-201001-0002_Ekonomicky_pohlad_v_ramci_diagnostiky_a_terapie_kolorektalneho_karcinomu.php weekly 0.7 /artkey/far-201001-0008_Metastazujici_karcinom_ledviny-soucasne_moznosti_lecby.php weekly 0.7 /artkey/far-201001-0009_Moznosti_ovlivneni_imunitniho_systemu_nutraceutiky.php weekly 0.7 /artkey/far-201001-0010_Farmakokinetika_a_klinicke_aplikace_vybranych_imunosupresiv_II.php weekly 0.7 /artkey/far-201001-0003_Pneumokokove_vakciny.php weekly 0.7 /artkey/far-201001-0004_Soucasnost_registrovanych_HPV_vakcin.php weekly 0.7 /artkey/far-201001-0005_Chripka-ockovani_je_zakladem_prevence.php weekly 0.7 /artkey/far-201001-0006_Rotavirove_gastroenteritidy_vakcinace.php weekly 0.7 /artkey/far-201001-0007_Proc_je_vhodne_ockovani_proti_klistove_meningoencefalitide.php weekly 0.7 /artkey/far-201001-0001_Seven_8220_Pillars_of_Wisdom_8221_for_Maximally_Precise_Therapeutic_Drug_Management.php weekly 0.7 /artkey/far-201001-0011_Odesel_prof_MUDr_Peter_Visnovsky_CSc.php weekly 0.7 /magno/far/2010/mn2.php weekly 0.7 /artkey/far-201002-0001_Nemoci_s_bronchialni_obstrukci_soucasna_a_perspektivni_lecba.php weekly 0.7 /artkey/far-201002-0002_Vyznam_sledovani_spotreby_leciv_ve_farmakoepidemiologii_na_prikladech_longitudinalnich_studii_inh.php weekly 0.7 /artkey/far-201002-0006_Role_imunosupresivni_terapie_ve_vztahu_k_vyskytu_nadorovych_onemocneni_po_organove_transplantaci.php weekly 0.7 /artkey/far-201002-0007_Tumor_necrosis_factor_jeho_vyznam_v_patogenezi_a_terapii_nespecifickych_strevnich_zanetu_revmat.php weekly 0.7 /artkey/far-201002-0008_Moznosti_stanoveni_cyklosporinu_A_v_terapeutickem_monitorovani_leku.php weekly 0.7 /artkey/far-201002-0009_Imunosuprese_po_transplantaci_ledviny.php weekly 0.7 /artkey/far-201002-0003_Budouci_lecba_astma_bronchiale.php weekly 0.7 /artkey/far-201002-0004_Postaveni_inhalacnich_anticholinergik_v_lecbe_chronicke_obstrukcni_plicni_nemoci_CHOPN.php weekly 0.7 /artkey/far-201002-0005_Pouziti_inhalacnich_kortikosteroidu_u_ruznych_typu_bronchialnich_obstrukci.php weekly 0.7 /artkey/far-201002-0010_Abatacept_a_jeho_pouziti_u_revmatoidni_artritidy.php weekly 0.7 /artkey/far-201002-0011_Za_legendou_ceskoslovenske_a_mezinarodni_farmakologie_prof_MUDr_Dr_h_c_Helenou_Raskovou_DrSc.php weekly 0.7 /artkey/far-201002-0012_Lekovy_bulletin_8222_The_medical_letter_on_drugs_and_therapeutics_8220_vychazi_v_USA_jiz_52_let.php weekly 0.7 /magno/far/2010/mn3.php weekly 0.7 /artkey/far-201003-0002_Potencovane_peniciliny-spotreba_a_naklady_v_CR_v_letech_1997-2008.php weekly 0.7 /artkey/far-201003-0003_Stanoveni_plazmatickych_koncentraci_imipenemu.php weekly 0.7 /artkey/far-201003-0009_Teratogenita_lieciv_a_jej_vyznam_pre_racionalnu_farmakoterapiu.php weekly 0.7 /artkey/far-201003-0010_Aprepitant.php weekly 0.7 /artkey/far-201003-0004_Nadorova_angiogeneze.php weekly 0.7 /artkey/far-201003-0005_Antiangiogenni_leky_v_klinicke_praxi.php weekly 0.7 /artkey/far-201003-0006_Leky_cilene_proti_cevam.php weekly 0.7 /artkey/far-201003-0007_Faslodex_500_a_nove_moznosti_lecby.php weekly 0.7 /artkey/far-201003-0008_Vysledky_dlouhodobe_klinicke_studie_prodlouzeni_preziti_u_pacientu_s_metastatickym_karcinomem_pr.php weekly 0.7 /artkey/far-201003-0001_Slovo_uvodem.php weekly 0.7 /artkey/far-201003-0013_Blahoprejeme_k_zivotnimu_jubileu_prof_Kvetinovi.php weekly 0.7 /artkey/far-201003-0011_Certolizumab_pegol.php weekly 0.7 /artkey/far-201003-0014_Cest_jej_pamiatke.php weekly 0.7 /artkey/far-201003-0012_Pocatky_klinicke_farmakologie_v_ceskych_zemich.php weekly 0.7 /magno/far/2010/mn4.php weekly 0.7 /artkey/far-201004-0001_Slovo_uvodem.php weekly 0.7 /artkey/far-201004-0002_Soucasny_pohled_na_spotrebu_a_pouzivani_emoliencii.php weekly 0.7 /artkey/far-201004-0003_Kozni_nadory_a_transplantace_ledviny-vysledky_statisticke_analyzy_transplantacniho_centra_Fakul.php weekly 0.7 /artkey/far-201004-0007_Spolehlivost_pocitacovych_programu_poskytujicich_elektronickou_podporou_preskripce_v_oblasti_leko.php weekly 0.7 /artkey/far-201004-0008_Biologicka_terapie_v_revmatologii.php weekly 0.7 /artkey/far-201004-0009_Systemy_rizeni_rizik_leciv_a_programy_omezeneho_pristupu_k_lecivum_v_USA.php weekly 0.7 /artkey/far-201004-0010_Prevence_a_lecba_sekundarni_hyperparatyreozy_pri_chronickem_onemocneni_ledvin.php weekly 0.7 /artkey/far-201004-0011_Komentar_ke_clanku_Expanded_studies_of_piperacillin_tazobactam_formulations_variations_among_bra.php weekly 0.7 /artkey/far-201004-0012_Lekova_interakce_mezi_lamotriginem_a_kyselinou_valproovou_uzivanymi_pri_porodu_a_behem_kojeni.php weekly 0.7 /artkey/far-201004-0004_Vliv_antibioticke_lecby_na_vyvoj_bakterialni_rezistence.php weekly 0.7 /artkey/far-201004-0005_Moznosti_fluorochinolonu_v_soucasne_klinicke_praxi.php weekly 0.7 /artkey/far-201004-0006_Daptomycin-nove_antibiotikum_pro_lecbu_zavaznych_infekci_zpusobenych_nekterymi_grampozitivnimi.php weekly 0.7 /artkey/far-201004-0013_Kongres_ovladly_nove_poznatky_z_farmakologie.php weekly 0.7 /magno/far/2009/mn1.php weekly 0.7 /artkey/far-200901-0002_Terapeuticke_monitorovani_gentamicinu_u_novorozencu_v_kritickem_stavu_behem_prvniho_tydne_postnatal.php weekly 0.7 /artkey/far-200901-0010_Zprava_z_58_farmakologickych_dnu.php weekly 0.7 /artkey/far-200901-0006_Virova_hepatitida_C.php weekly 0.7 /artkey/far-200901-0007_Funkcni_dyspepsie.php weekly 0.7 /artkey/far-200901-0008_Ovlivneni_metabolizmu_cholesterolu_aminobisfosfonaty.php weekly 0.7 /artkey/far-200901-0009_Akutni_perikarditida_jako_nezadouci_ucinek_mesalazinu.php weekly 0.7 /artkey/far-200901-0003_Nezadouci_ucinky_leku_na_kuzi.php weekly 0.7 /artkey/far-200901-0004_Lecba_akne.php weekly 0.7 /artkey/far-200901-0005_Nejcastejsi_sexualne_prenosne_infekce_a_moznosti_jejich_lecby.php weekly 0.7 /artkey/far-200901-0001_Clinical_Pharmacology-current_importance_and_future_perspectives.php weekly 0.7 /magno/far/2009/mn2.php weekly 0.7 /artkey/far-200902-0001_Farmakoterapie_v_kardiologii.php weekly 0.7 /artkey/far-200902-0002_Rizikove_kombinacie_kardiovaskularnych_lieciv_u_starsich_pacientov_a_faktory_zvysujuce_pravdepodobn.php weekly 0.7 /artkey/far-200902-0007_Farmakologicke_moznosti_embryoprotektivni_terapie_infertilnich_zen.php weekly 0.7 /artkey/far-200902-0008_Muze_konzumace_kavy_ovlivnit_riziko_rozvoje_diabetu_2_typu.php weekly 0.7 /artkey/far-200902-0009_Azolova_antimykotika_mechanizmy_lekovych_interakci.php weekly 0.7 /artkey/far-200902-0010_Vliv_financnich_limitu_na_preskripci_leciv_v_Ceske_republice_v_roce_2006.php weekly 0.7 /artkey/far-200902-0004_Lecba_akutniho_srdecniho_selhani.php weekly 0.7 /artkey/far-200902-0005_Soucasny_pohled_na_antiarytmika.php weekly 0.7 /artkey/far-200902-0006_Farmakologicka_lecba_ischemicke_choroby_dolnich_koncetin.php weekly 0.7 /artkey/far-200902-0003_Komentar_k_clanku_Rizikove_kombinacie_kardiovaskularnych_lieciv.php weekly 0.7 /artkey/far-200902-0011_Zprava_z_konference.php weekly 0.7 /magno/far/2009/mn3.php weekly 0.7 /artkey/far-200903-0001_doc_MUDr_Milan_Grundmann_CSc_septuagesimo_anno.php weekly 0.7 /artkey/far-200903-0003_Mozne_interakce_rokuronia_s_jaternimi_mikrosomalnimi_cytochromy_P450.php weekly 0.7 /artkey/far-200903-0008_Farmakokinetika_a_klinicke_aplikace_vybranych_imunosupresiv_I.php weekly 0.7 /artkey/far-200903-0009_Nove_pohledy_na_lecbu_osteoporozy.php weekly 0.7 /artkey/far-200903-0004_Soucasna_farmakoterapie_glaukomu.php weekly 0.7 /artkey/far-200903-0005_Farmakoterapie_uveitid.php weekly 0.7 /artkey/far-200903-0006_Lecba_chronicke_blefaritidy.php weekly 0.7 /artkey/far-200903-0007_Problematika_vekem_podminene_makularni_degenerace_a_soucasne_moznosti_jeji_lecby_se_zamerenim_na_bi.php weekly 0.7 /artkey/far-200903-0002_Farmakoterapie_v_oftalmologii.php weekly 0.7 /artkey/far-200903-0010_Rivaroxaban_v_prevenci_tromboembolizmu_po_velkych_ortopedickych_operacich.php weekly 0.7 /magno/far/2009/mn4.php weekly 0.7 /artkey/far-200904-0003_Neuropsychiatricke_projevy_u_intoxikace_digoxinem.php weekly 0.7 /artkey/far-200904-0004_Systemova_enzymoterapie_po_operacich_vyhrezu_bederni_meziobratlove_plotenky.php weekly 0.7 /artkey/far-200904-0009_Cyklosporin_A_farmakokinetika_monitorovani_a_jeho_pouziti_v_revmatologii.php weekly 0.7 /artkey/far-200904-0001_Profesor_MUDr_Jiri_Lenfeld_a_jeho_vyznam_pro_vyuku_klinicke_farmakologie.php weekly 0.7 /artkey/far-200904-0005_Farmakoterapie_bolesti.php weekly 0.7 /artkey/far-200904-0006_Farmakoterapie_akutni_bolesti_u_hospitalizovanych_pacientu-prehled.php weekly 0.7 /artkey/far-200904-0007_Novinky_v_lecbe_chronicke_bolesti.php weekly 0.7 /artkey/far-200904-0008_Farmakoterapie_neuropaticke_bolesti.php weekly 0.7 /artkey/far-200904-0002_Bolest_nelze_v_medicinske_oblasti_podcenovat.php weekly 0.7 /artkey/far-200904-0011_Zprava_ze_sympozia_klinicke_farmakologie.php weekly 0.7 /artkey/far-200904-0010_Sitagliptin.php weekly 0.7 /magno/far/2008/mn1.php weekly 0.7 /artkey/far-200801-0001_Antitrombotika_patria_k_najdiskutovanejsim_liekom.php weekly 0.7 /artkey/far-200801-0002_Informovanost_Percepce_rizik_a_compliance_pacientu_uzivajicich_warfarin.php weekly 0.7 /artkey/far-200801-0010_Zprava_z_3_cesko-slovenske_konference_klinicke_farmacie.php weekly 0.7 /artkey/far-200801-0011_Deset_let_kurzu_Sepse_a_MODS_v_Ostrave.php weekly 0.7 /artkey/far-200801-0006_Soucasna_lecba_relaps-remitentni_roztrousene_sklerozy_a_perspektivy_do_budoucna.php weekly 0.7 /artkey/far-200801-0007_Leky_a_kojeni.php weekly 0.7 /artkey/far-200801-0008_Sepse_v_detskem_veku.php weekly 0.7 /artkey/far-200801-0009_Systemova_antimykotika.php weekly 0.7 /artkey/far-200801-0003_Percepcia_rizika_pri_antiagregacnej_preventivnej_terapii.php weekly 0.7 /artkey/far-200801-0004_Hodnotenie_compliance_u_pacientov_v_ramci_aspirinovej_prevencie.php weekly 0.7 /artkey/far-200801-0005_Alfimepraza-nove_fibrinolytikum.php weekly 0.7 /magno/far/2008/mn2.php weekly 0.7 /artkey/far-200802-0002_Rezistence_komunitnich_kmenu_Streptococcus_agalactiae_k_makrolidovym_antibiotikum.php weekly 0.7 /artkey/far-200802-0006_Soucasne_moznosti_lecby_koznich_a_sliznicnich_mykoz.php weekly 0.7 /artkey/far-200802-0001_Biologicka_liecba_a_racionalna_farmakoterapia.php weekly 0.7 /artkey/far-200802-0007_Pouzivanie_potencialne_nevhodnych_lieciv_pre_starsich_pacientov_v_regione_byvaleho_Ceskoslovenska.php weekly 0.7 /artkey/far-200802-0003_Biologicka_terapie_v_gastroenterologii.php weekly 0.7 /artkey/far-200802-0004_Cielena_liecba_v_onkologii.php weekly 0.7 /artkey/far-200802-0005_Biologicka_lecba_v_dermatologii.php weekly 0.7 /magno/far/2008/mn3.php weekly 0.7 /artkey/far-200803-0002_Percepcia_rizika_liecby_a_adherencia_lekarov_k_sekundarnej_farmakoterapii_po_infarkte_myokardu.php weekly 0.7 /artkey/far-200803-0007_Komentar_ke_clanku_Glycylcykliny-nova_skupina_antibiotik.php weekly 0.7 /artkey/far-200803-0006_Glycylcykliny-nova_skupina_antibiotik.php weekly 0.7 /artkey/far-200803-0008_Hodnoceni_kvality_preskripce.php weekly 0.7 /artkey/far-200803-0001_Farmakoterapie_v_gastroenterologii.php weekly 0.7 /artkey/far-200803-0003_Soucasne_moznosti_terapie_drazdiveho_tracniku.php weekly 0.7 /artkey/far-200803-0004_Pokroky_v_terapii_chronickych_virovych_hepatitid_B_a_C.php weekly 0.7 /artkey/far-200803-0005_Polekove_akutni_pankreatitidy_u_idiopatickych_strevnich_zanetu.php weekly 0.7 /magno/far/2008/mn4.php weekly 0.7 /artkey/far-200804-0002_Informovanost_percepce_rizik_a_compliance_pacientu_lecenych_systemovymi_glukokortikoidy_dotazniko.php weekly 0.7 /artkey/far-200804-0009_Komentar_ke_clanku_8222_Ockovani_proti_HPV_8220.php weekly 0.7 /artkey/far-200804-0013_Zprava_z_X_sympozia_klinicke_farmacie_Rene_Macha_8222_Vinobrani_8220_zkusenosti.php weekly 0.7 /artkey/far-200804-0011_Farmaceuticka_starostlivost_a_jej_aplikacia_v_klinickej_praxi.php weekly 0.7 /artkey/far-200804-0001_30_let_klinicke_farmakologie_ve_zdravotnickych_zarizenich_Ceske_republiky.php weekly 0.7 /artkey/far-200804-0012_Dosavadni_zkusenosti_z_kontrol_historicke_preskripce_leku_na_recept.php weekly 0.7 /artkey/far-200804-0003_Editorial.php weekly 0.7 /artkey/far-200804-0004_Antibioticka_lecba_a_profylaxe_nekterych_infekci_v_tehotenstvi.php weekly 0.7 /artkey/far-200804-0005_Farmakoterapie_predcasneho_porodu-tokolytika_kortikosteroidy.php weekly 0.7 /artkey/far-200804-0006_Farmakologicka_prevence_krvaceni_u_cisarskeho_rezu.php weekly 0.7 /artkey/far-200804-0007_Kontraceptiva_v_gynekologicke_praxi.php weekly 0.7 /artkey/far-200804-0008_Ockovani_proti_HPV.php weekly 0.7 /artkey/far-200804-0010_Soucasny_nazor_na_problematiku_hormonalni_substitucni_terapie.php weekly 0.7 /magno/far/2007/mn1.php weekly 0.7 /artkey/far-200701-0001_8222_Orphan_8220_lieky.php weekly 0.7 /artkey/far-200701-0002_Individualni_rozdily_farmakokinetiky_Taxolu_u_pacientek_s_rakovinou_prsu.php weekly 0.7 /artkey/far-200701-0008_Prehled_lokalnich_kortikosteroidu_v_dermatologii_2-rozdeleni_lokalnich_kortikosteroidu_registrov.php weekly 0.7 /artkey/far-200701-0009_Polypragmazie_u_67leteho_diabetika.php weekly 0.7 /artkey/far-200701-0003_Farmakologicka_lecba_hyperaktivniho_mocoveho_mechyre_a_urgentni_inkontinence.php weekly 0.7 /artkey/far-200701-0004_Soucasne_moznosti_farmakologicke_lecby_erektilni_dysfunkce.php weekly 0.7 /artkey/far-200701-0005_Moznosti_lecby_cysticke_fibrozy-1_cast.php weekly 0.7 /artkey/far-200701-0006_Fabryho_choroba_a_moznosti_jej_liecby_enzymovou_substitucnou_terapiou.php weekly 0.7 /artkey/far-200701-0007_Nove_terapeuticke_moznosti_plucnej_arteriovej_hypertenzie.php weekly 0.7 /magno/far/2007/mn2.php weekly 0.7 /artkey/far-200702-0001_Uvodni_slovo.php weekly 0.7 /artkey/far-200702-0002_Retrospektivna_analyza_neziaducich_ucinkov_antiepileptickej_terapie_u_deti_a_adolescentov_s_epileps.php weekly 0.7 /artkey/far-200702-0007_Terapeuticke_monitorovani_leku_pomoci_elektromigracnich_metod.php weekly 0.7 /artkey/far-200702-0008_Moznosti_lecby_cysticke_fibrozy-2_cast.php weekly 0.7 /artkey/far-200702-0009_Hodnoceni_klinickeho_a_ekonomickeho_prospechu_lecby_nadvahy_sibutraminem_Meridii_ve_vseobecne_lek.php weekly 0.7 /artkey/far-200702-0003_Mirneni_bolesti_u_umirajicich_nemocnych.php weekly 0.7 /artkey/far-200702-0004_Nutricni_podpora_v_terminalni_peci.php weekly 0.7 /artkey/far-200702-0005_Horecka_neznameho_puvodu_u_granulocytopenickych_nemocnych_tzv_febrilni_neutropenie.php weekly 0.7 /artkey/far-200702-0006_Soucasne_trendy_antibioticke_terapie_v_lecbe_tezke_sepse.php weekly 0.7 /magno/far/2007/mn3.php weekly 0.7 /artkey/far-200703-0001_Klinicke_hodnoceni_leciv.php weekly 0.7 /artkey/far-200703-0002_Vyznam_davkoveho_intervalu_pri_leceni_time-dependentnimi_antibiotiky_priklady_terapeutickeho_monit.php weekly 0.7 /artkey/far-200703-0008_Thalidomid-8222_novodoby_comeback_8220.php weekly 0.7 /artkey/far-200703-0009_CYP2D6_a_jeho_klinicky_vyznam.php weekly 0.7 /artkey/far-200703-0010_Leky_a_tehotenstvi.php weekly 0.7 /artkey/far-200703-0011_Priklady_systemu_rizeni_rizik_a_bezpecnost_leciv.php weekly 0.7 /artkey/far-200703-0003_Soucasne_moznosti_a_nove_perspektivy_systemove_lecby_karcinomu_prsu.php weekly 0.7 /artkey/far-200703-0004_Hormonalni_regulace_a_moznosti_jejiho_ovlivneni_v_lecbe_karcinomu_prostaty.php weekly 0.7 /artkey/far-200703-0005_O_cem_se_diskutuje_v_oblasti_klinickych_studii.php weekly 0.7 /artkey/far-200703-0006_Spoluprace_zkousejiciho_se_zadavatelem_v_klinickem_hodnoceni_leciv.php weekly 0.7 /artkey/far-200703-0007_Lekarska_etika_v_kontextu_klinickeho_vyzkumu.php weekly 0.7 /magno/far/2006/mn1.php weekly 0.7 /artkey/far-200601-0001_20_rocnik_casopisu_Klinicka_farmakologie_a_farmacie.php weekly 0.7 /artkey/far-200601-0002_Survey_of_the_management_of_deep_vein_thrombosis_in_general_practice_in_the_Czech_republic.php weekly 0.7 /artkey/far-200601-0014_Doc_MUDr_Danuse_Waitzova_75_let.php weekly 0.7 /artkey/far-200601-0010_Existuje_vztah_mezi_statiny_a_cholinergnim_systemem.php weekly 0.7 /artkey/far-200601-0011_Periferni_neuropatie_jako_nezadouci_ucinek_statinu.php weekly 0.7 /artkey/far-200601-0012_Pagetova_kostni_choroba_a_pokroky_v_jeji_lecbe.php weekly 0.7 /artkey/far-200601-0013_Komplexni_pohled_na_infekce_urogenitalniho_traktu.php weekly 0.7 /artkey/far-200601-0003_Analoga_inzulinu.php weekly 0.7 /artkey/far-200601-0004_Peroralni_antidiabetika.php weekly 0.7 /artkey/far-200601-0005_Terapie_diabeticke_neuropatie.php weekly 0.7 /artkey/far-200601-0006_Uziti_nesteroidnich_antirevmatik_v_lecbe_bolesti_hlavy_tenzniho_typu.php weekly 0.7 /artkey/far-200601-0007_Profylakticka_lecba_migreny.php weekly 0.7 /artkey/far-200601-0008_Bolesti_hlavy_vyvolane_farmakologicky_ucinnymi_latkami_nebo_jejich_vysazenim.php weekly 0.7 /artkey/far-200601-0009_Bolest_hlavy_ako_neziaduci_ucinok_lieku.php weekly 0.7 /magno/far/2006/mn2.php weekly 0.7 /artkey/far-200602-0001_Editorial.php weekly 0.7 /artkey/far-200602-0002_Moznosti_vyuziti_biotestu_s_Artemia_salina_pri_studovani_toxikologickych_ucinku_inhibitoru_cyklin-d.php weekly 0.7 /artkey/far-200602-0003_Analyza_vztahu_mezi_farmakokinetikou_ucinkem_a_nezadoucimi_ucinky_metotrexatu_v_inicialni_fazi_sys.php weekly 0.7 /artkey/far-200602-0004_Soucasne_moznosti_lecby_infekci_zpusobenych_rezistentnimi_grampozitivnimi_bakteriemi.php weekly 0.7 /artkey/far-200602-0011_Farmakoterapie_a_zdravotni_rizika_obezity.php weekly 0.7 /artkey/far-200602-0012_Ibandronat-novy_ucinny_aminobisfosfonat_v_lecbe_postmenopauzalni_osteoporozy.php weekly 0.7 /artkey/far-200602-0013_Jak_se_pise_clanek_do_prestizniho_mezinarodniho_casopisu.php weekly 0.7 /artkey/far-200602-0005_Alergicka_ryma.php weekly 0.7 /artkey/far-200602-0006_Diagnostika_a_lecba_chronicke_rhinosinusitis.php weekly 0.7 /artkey/far-200602-0007_Laryngitis_acuta-farmakologicke_aspekty_terapie.php weekly 0.7 /artkey/far-200602-0008_Farmakoterapie_stabilizovane_chronicke_obstrukcni_plicni_nemoci_v_Ceske_republice.php weekly 0.7 /artkey/far-200602-0009_Antibioticka_lecba_bakterialnich_zanetu_plic.php weekly 0.7 /artkey/far-200602-0010_Farmakologie_latek_zneuzivanych_vdechovanim.php weekly 0.7 /magno/far/2006/mn3.php weekly 0.7 /artkey/far-200603-0001_Hepatoprotektiva.php weekly 0.7 /artkey/far-200603-0002_Porovnanie_klinickeho_stavu_a_farmakoterapie_u_pacientov_s_hypertenziou_a_sucasne_s_diabetom_mellit.php weekly 0.7 /artkey/far-200603-0003_Retrospektivni_analyza_klinicke_praxe_lecby_metastatickeho_postizeni_skeletu_u_pacientek_s_karcinom.php weekly 0.7 /artkey/far-200603-0010_Novinky_v_lecbe_pokrocilych_nadoru_hlavy_a_krku.php weekly 0.7 /artkey/far-200603-0012_XV_sympozium_klinickej_farmacie_Nove_lieky_a_nove_liekove_formy_v_klinickej_praxi.php weekly 0.7 /artkey/far-200603-0011_Napady_pro_ctenare_klinickych_studii.php weekly 0.7 /artkey/far-200603-0009_Zavazne_ziskane_chlopnove_srdcove_chyby_po_anorektikach-antidepresivach-mozne_rizika_dlhodobej.php weekly 0.7 /artkey/far-200603-0004_Indikatory_kvality_farmakoterapie_v_geriatrii.php weekly 0.7 /artkey/far-200603-0005_Hypertenze-lecba_ve_vyssim_veku.php weekly 0.7 /artkey/far-200603-0006_Dekubitus-jak_dale_v_diagnostice_prevenci_a_lecbe.php weekly 0.7 /artkey/far-200603-0007_Moznosti_probiotik_v_hepatologii.php weekly 0.7 /artkey/far-200603-0008_Hepatoprotektiva.php weekly 0.7 /magno/far/2006/mn4.php weekly 0.7 /artkey/far-200604-0001_Dermatologicke_zamysleni.php weekly 0.7 /artkey/far-200604-0002_SPOTREBA_ANTIBAKTERIALNICH_LATEK_A_ANTIMYKOTIK_NA_CHIRURGICKEM_ODDELENI_NSP_V_LETECH_2000-2004.php weekly 0.7 /artkey/far-200604-0003_Retrospektivni_analyza_klinicke_praxe_lecby_metastatickeho_postizeni_skeletu_u_karcinomu_prostaty_v.php weekly 0.7 /artkey/far-200604-0010_Komunikacia_pri_riziku_liekov.php weekly 0.7 /artkey/far-200604-0011_8_konference_klinicke_farmakologie_13_konference_terapeutickeho_monitorovani_hladin_leciv_10_k.php weekly 0.7 /artkey/far-200604-0012_Zprava_z_celosvetoveho_farmakologickeho_kongresu_IUPHAR_2006.php weekly 0.7 /artkey/far-200604-0008_Metodika_studia_spotreb_leku.php weekly 0.7 /artkey/far-200604-0009_NEZIADUCI_UCINOK_LIEKU_A_JEHO_HODNOTENIE.php weekly 0.7 /artkey/far-200604-0004_Receptory_pro_epidermalni_rustove_faktory_a_jejich_vyznam_pro_maligni_transformaci_solidnich_nadoru.php weekly 0.7 /artkey/far-200604-0005_Cytotoxicka_aktivita_boheminu_in_vitro_na_primarnich_nadorovych_bunkach.php weekly 0.7 /artkey/far-200604-0006_PREHLED_LOKALNICH_KORTIKOSTEROIDU_V_DERMATOLOGII_1_Moznosti_lecby_koznich_chorob_kortikosteroidnim.php weekly 0.7 /artkey/far-200604-0007_Lecba_alopecie.php weekly 0.7 /magno/far/2005/mn1.php weekly 0.7 /artkey/far-200501-0001_Adefovir_dipivoxil-dalsi_nadeje_pro_nemocne_s_chronickou_hepatitidou_B.php weekly 0.7 /artkey/far-200501-0002_Problemy_vnimania_liekoveho_rizika_v_skupine_monokomponentnych_analgetickych_pripravkov_vo_vztahu_k.php weekly 0.7 /artkey/far-200501-0003_Retrospektivni_analyza_preskripce_lecivych_pripravku_plne_hrazenych_pacientem_III.php weekly 0.7 /artkey/far-200501-0004_Manazment_farmakoterapie_u_pacientov_s_esencialnou_hypertenziou_na_zaklade_monitorovania_krvneho_tl.php weekly 0.7 /artkey/far-200501-0013_Inhibitory_ACE_v_sekundarni_prevenci_ICHS-Studie_PEACE.php weekly 0.7 /artkey/far-200501-0015_Sprava_z_XII_konferencie_klinickej_farmakologie_v_Bratislave.php weekly 0.7 /artkey/far-200501-0016_Sekcia_klinickej_farmacie_Slovenskej_farmaceutickej_spolocnosti_a_aktivity_slovenskych_klinickych_f.php weekly 0.7 /artkey/far-200501-0017_VI_rocnik_Vinobrani_klinicke_farmacie.php weekly 0.7 /artkey/far-200501-0019_Profesor_MUDr_Emil_Starkenstein_18_12_1884_8201-8201_6_11_1942-Osobnost_a_dilo_vyznamn.php weekly 0.7 /artkey/far-200501-0008_Thalidomid.php weekly 0.7 /artkey/far-200501-0009_Ichtamol_a_dehty_v_soucasne_dermatologicke_terapii.php weekly 0.7 /artkey/far-200501-0010_Rizika_fluoridove_suplementace_u_deti_novy_ekotoxikologicky_fenomen.php weekly 0.7 /artkey/far-200501-0011_Vitamin_C-co_o_nom_ne_vieme.php weekly 0.7 /artkey/far-200501-0012_Farmakologicky_profil_brimonidinu-noveho_lieciva_na_terapiu_glaukomu.php weekly 0.7 /artkey/far-200501-0005_Ezetimib-prvni_zastupce_selektivnich_inhibitoru_cholesterolove_absorpce.php weekly 0.7 /artkey/far-200501-0006_Soucasny_stav_a_perspektivy_lecby_chronickeho_srdecniho_selhani.php weekly 0.7 /artkey/far-200501-0007_Lekove_interakce_warfarinu_s_kardiovaskularnimi_leky.php weekly 0.7 /artkey/far-200501-0014_Lecba_chronicke_hepatitidy_B_adefovir_dipivoxilem.php weekly 0.7 /artkey/far-200501-0018_Infliximab_v_klinicke_lecebne_praxi.php weekly 0.7 /magno/far/2005/mn2.php weekly 0.7 /artkey/far-200502-0002_Porovnani_vybranych_peroralnich_originalnich_a_generickych_leku_pouzivanych_v_kardiologii_na_zaklad.php weekly 0.7 /artkey/far-200502-0008_Farmakogenomika_a_nutrigenomika_komplexni_interakce_genu_s_prostredim.php weekly 0.7 /artkey/far-200502-0009_Postavenie_lamotriginu_v_liecbe_bipolarnej_depresie.php weekly 0.7 /artkey/far-200502-0001_Uvaha_o_ucebnicich_farmakologie.php weekly 0.7 /artkey/far-200502-0010_Molekularni_mechanizmy_ucinku_antiandrogenu_bicalutamidu.php weekly 0.7 /artkey/far-200502-0011_Deset_let_farmakologicke_inhibice_v_ATP-vazebnem_miste_proteinkinaz-prispevek_ceske_enzymologie.php weekly 0.7 /artkey/far-200502-0012_Malarie.php weekly 0.7 /artkey/far-200502-0003_Malarie_a_jeji_lecba.php weekly 0.7 /artkey/far-200502-0004_Farmakoterapie_malarie_v_Ceske_republice.php weekly 0.7 /artkey/far-200502-0005_Pokrok_v_lecbe_visceralni_leishmaniozy.php weekly 0.7 /artkey/far-200502-0006_Pneumocystova_pneumonie.php weekly 0.7 /artkey/far-200502-0007_Soucasna_lecba_helmintoz.php weekly 0.7 /magno/far/2005/mn3.php weekly 0.7 /artkey/far-200503-0002_Spotreba_hypolipidemik_v_Ceske_republice_v_letech_1989-2003.php weekly 0.7 /artkey/far-200503-0003_Compliance_pri_lecbe_hypolipidemiky.php weekly 0.7 /artkey/far-200503-0012_Farmakokinetika_mykofenolat_mofetilu_u_autoimunitnich_chorob_v_detskem_veku.php weekly 0.7 /artkey/far-200503-0014_Jaroslav_Kvetina-petasedmdesatilety.php weekly 0.7 /artkey/far-200503-0015_Prof_MUDr_Jiri_Elis_DrSc_petasedmdesatnik.php weekly 0.7 /artkey/far-200503-0008_Kvalita_zivota_u_chronickych_onemocneni_ve_svetle_novejsich_modelu_zdravi_a_nemoci.php weekly 0.7 /artkey/far-200503-0009_Kombinacni_lecba_hypertenze.php weekly 0.7 /artkey/far-200503-0010_Fibrilace_sini-terapeuticke_postupy_a_cile.php weekly 0.7 /artkey/far-200503-0011_Biologicka_lecba_revmatoidni_artritidy.php weekly 0.7 /artkey/far-200503-0001_O_nazvoslovi_leciv.php weekly 0.7 /artkey/far-200503-0013_Znizovanie_medicinskych_omylov.php weekly 0.7 /artkey/far-200503-0004_Statiny_od_lipidologie_ke_kardiologii.php weekly 0.7 /artkey/far-200503-0005_Prinos_statinu_v_geriatrii.php weekly 0.7 /artkey/far-200503-0006_Statiny_v_onkologii.php weekly 0.7 /artkey/far-200503-0007_M_zu_byt_problemy_pri_liecbe_statinmi.php weekly 0.7 /magno/far/2005/mn4.php weekly 0.7 /artkey/far-200504-0002_Mozny_prediktivni_vyznam_metabolickeho_syndromu_inzulinove_rezistence_u_ischemickych_cevnich_mozkov.php weekly 0.7 /artkey/far-200504-0003_Monitorovani_terapie_astmatickych_pacientu_v_lekarne.php weekly 0.7 /artkey/far-200504-0011_55_Cesko-Slovenske_farmakologicke_dny.php weekly 0.7 /artkey/far-200504-0012_10_Cesko-Slovenska_mezioborova_toxikologicka_konference_Olomouc_14_-16_9_2005.php weekly 0.7 /artkey/far-200504-0013_Publikace_ceskych_autoru_v_JAME_upozornila_na_caste_uziti_leciv_nevhodnych_ve_stari.php weekly 0.7 /artkey/far-200504-0014_Sprava_z_II_Slovensko-ceskej_konferencie_klinickej_farmakologie.php weekly 0.7 /artkey/far-200504-0015_Sto_let_ucebnice_FARMAKOLOGIE-Karel_Chodounsky_Praha_Bursik_a_Kohout_1905_stran_466.php weekly 0.7 /artkey/far-200504-0009_Imunomodulace_u_recidivujicich_infekci_dychacich_cest.php weekly 0.7 /artkey/far-200504-0010_Nezadouci_ucinky_a_interakce_novych_antiepileptik.php weekly 0.7 /artkey/far-200504-0001_Farmakoterapie_v_gynekologii.php weekly 0.7 /artkey/far-200504-0004_Aromataza_jako_cil_v_antihormonalni_lecbe.php weekly 0.7 /artkey/far-200504-0005_Hormonalni_lecba_casneho_karcinomu_prsu.php weekly 0.7 /artkey/far-200504-0006_Hormonalni_kontracepce.php weekly 0.7 /artkey/far-200504-0007_Kombinovana_oralni_kontraceptiva_s_pozitivnim_vlivem_na_plet_z_dermatologickeho_hlediska.php weekly 0.7 /artkey/far-200504-0008_Osteoporoza_a_cile_jeji_lecby.php weekly 0.7 /magno/far/2004/mn1.php weekly 0.7 /artkey/far-200401-0002_Vliv_selekcniho_tlaku_vybranych_antibiotik_na_rezistenci_nejcasteji_se_vyskytujicich_gramnegativnic.php weekly 0.7 /artkey/far-200401-0003_Zmirnovani_zadrhavani_v_reci_u_deti_a_mladistvych_s_balbuties_po_aplikaci_beta2_sympatomimetika_for.php weekly 0.7 /artkey/far-200401-0010_Primarni_hypertenze_v_detskem_veku-zkusenosti_s_pouzitim_felodipinu.php weekly 0.7 /artkey/far-200401-0011_COMET-Carvedilol_or_Metoprolol_European_Trial-mortalitni_studie_srovnavajici_dva_betablokatory.php weekly 0.7 /artkey/far-200401-0012_VALIANT-Valsartan_captopril_nebo_oboji_u_infarktu_myokardu_komplikovaneho_srdecnim_selhanim_a_ne.php weekly 0.7 /artkey/far-200401-0014_Pocitacovy_program_-Profylaxe_hluboke_zilni_trombozy_a_plicni_embolizace-.php weekly 0.7 /artkey/far-200401-0015_Informace_z_5_Vinobrani_klinicke_farmacie.php weekly 0.7 /artkey/far-200401-0016_Syndrom_bolestiveho_ramene.php weekly 0.7 /artkey/far-200401-0004_Biologicke_ucinky_triterpenoidu_protinadorova_aktivita.php weekly 0.7 /artkey/far-200401-0013_Doc_MUDr_Josef_Klapetek_CSc.php weekly 0.7 /artkey/far-200401-0005_Leky_snizujici_ucinnost_antihypertenziv.php weekly 0.7 /artkey/far-200401-0006_Hyperhomocysteinemie_a_riziko_ischemickych_cevnich_mozkovych_prihod.php weekly 0.7 /artkey/far-200401-0007_Nezadouci_ucinky_leku_pouzivanych_v_revmatologii_a_zakladni_principy_sledovani_jejich_bezpecnosti_-.php weekly 0.7 /artkey/far-200401-0008_Lecba_depresivni_poruchy_v_pozdnim_veku.php weekly 0.7 /artkey/far-200401-0009_Leflunomid_v_lecbe_aktivni_revmatoidni_artritidy.php weekly 0.7 /magno/far/2004/mn2.php weekly 0.7 /artkey/far-200402-0002_Moznosti_rychleho_prukazu_ganciclovir_rezistentnich_kmenu_lidskeho_cytomegaloviru_HCMV_CMV_u_pac.php weekly 0.7 /artkey/far-200402-0003_Prvni_zkusenosti_s_podanim_anti-D_globulinu_u_deti_s_chronickou_formou_ITP.php weekly 0.7 /artkey/far-200402-0011_Hodnotenie_rizika_nesteroidovych_antiflogistik_Komentar_k_serii_clankov_o_NSA.php weekly 0.7 /artkey/far-200402-0012_prof_MUDr_Jiri_Lenfeld_CSc_18_4_1924-14_1_1994.php weekly 0.7 /artkey/far-200402-0013_Nedozita_jubilea_prof_MUDr_PhMr_Zdenka_Votavy_DrSc_a_doc_MUDr_Miroslava_Mraze_DrSc.php weekly 0.7 /artkey/far-200402-0001_Davejme_Nahode_do_jeji_jest-.php weekly 0.7 /artkey/far-200402-0004_Neurofarmakologicka_podstata_pusobeni_memantinu_v_lecbe_Alzheimerovy_demence.php weekly 0.7 /artkey/far-200402-0005_Zakladni_charakteristiky_vybranych_imunosupresiv.php weekly 0.7 /artkey/far-200402-0006_Biologicke_ucinky_triterpenoidu_protizanetlive_antimikrobialni_hepatoprotektivni_analgeticke_a.php weekly 0.7 /artkey/far-200402-0007_Liekove_interakcie_na_urovni_cytochromov_P450_Cast_II_Interakcie_na_urovni_CYP2D6.php weekly 0.7 /artkey/far-200402-0008_Interakcie_nesteroidovych_antiflogistik_a_analgetik.php weekly 0.7 /artkey/far-200402-0009_Farmakoterapie_v_tehotenstvi-novy_projekt_webovych_stranek.php weekly 0.7 /artkey/far-200402-0010_Co_prinasi_klinicky_vyzkum_diabetu_ve_Fakultni_nemocnici_a_na_Lekarske_fakulte_Univerzity_Palackeho.php weekly 0.7 /magno/far/2004/mn3.php weekly 0.7 /artkey/far-200403-0002_Ucinek_rosiglitazonu_je_u_modelu_inzulinove_rezistence_a_dyslipidemie_modulovan_genetickym_pozadim.php weekly 0.7 /artkey/far-200403-0003_Problematika_rezistence_Helicobacter_pylori_k_antimikrobnim_lecivum.php weekly 0.7 /artkey/far-200403-0012_Nefrotoxicita_indometacinu_u_novorozencu.php weekly 0.7 /artkey/far-200403-0013_Studie_VALUE-valsartan_verzus_amlodipin_v_lecbe_hypertenze.php weekly 0.7 /artkey/far-200403-0014_Zprava_z_konferenci.php weekly 0.7 /artkey/far-200403-0015_Zprava_z_kongresu_Pokroky_ve_farmakoterapii_2004_pro_lekare_v_praxi_s_mezinarodni_ucasti.php weekly 0.7 /artkey/far-200403-0009_Terapeuticke_monoklonalni_protilatky_v_onkologii.php weekly 0.7 /artkey/far-200403-0010_Nezadouci_ucinky_amiodaronu.php weekly 0.7 /artkey/far-200403-0011_Inhibitory_angiotenzin_konvertujiciho_enzymu_a_antagoniste_angiotenzinu_u_pacientu_s_chronickym_one.php weekly 0.7 /artkey/far-200403-0001_Farmakoterapie_v_gastroenterologii.php weekly 0.7 /artkey/far-200403-0004_Konzervativni_lecba_Crohnovy_nemoci.php weekly 0.7 /artkey/far-200403-0005_Klinicky_vyznamne_interakce_leciv_gastrointestinalniho_traktu.php weekly 0.7 /artkey/far-200403-0006_Individualizace_farmakoterapie_inhibitory_tymidylat_syntazy_u_nadoru_gastrointestinalniho_traktu.php weekly 0.7 /artkey/far-200403-0007_Soucasna_terapie_primarnich_lymfomu_gastrointestinalniho_traktu.php weekly 0.7 /artkey/far-200403-0008_Lecba_bolesti_v_gastroenterologii.php weekly 0.7 /magno/far/2004/mn4.php weekly 0.7 /artkey/far-200404-0001_Pokroky_v_neurofarmakologii.php weekly 0.7 /artkey/far-200404-0002_Bola_liecba_akutnej_tonzilitidy_v_niektorych_regionoch_v_Slovenskej_republike_v_rokoch_1999-2002_ra.php weekly 0.7 /artkey/far-200404-0012_Zprava_z_33_evropskeho_sympozia_klinicke_farmacie_v_Praze_ESCP.php weekly 0.7 /artkey/far-200404-0013_9_mezioborova_slovensko-ceska_toxikologicka_konference_2004.php weekly 0.7 /artkey/far-200404-0014_Za_profesorem_MUDr_Vojtechem_Grossmannem_2_2_1922_-17_10_2004.php weekly 0.7 /artkey/far-200404-0015_MUDr_Ludvik_Stika_CSc_1925-2004.php weekly 0.7 /artkey/far-200404-0009_Analogy_prostaglandinov_v_liecbe_glaukomu.php weekly 0.7 /artkey/far-200404-0010_Lekove_interakce_antidepresiv_a_lithia.php weekly 0.7 /artkey/far-200404-0003_Antidepresiva_a_membranove_lipidy.php weekly 0.7 /artkey/far-200404-0004_Aripiprazol-antipsychotikum_s_novym_farmakodynamickym_ucinkem.php weekly 0.7 /artkey/far-200404-0005_Interakce_antipsychotik.php weekly 0.7 /artkey/far-200404-0006_Farmakoterapie_Alzheimerovy_choroby.php weekly 0.7 /artkey/far-200404-0007_Lecba_komplikovane_Parkinsonovy_nemoci.php weekly 0.7 /artkey/far-200404-0008_Antidepresiva_s_dualnim_pusobenim-ucinnost_a_indikace.php weekly 0.7 /artkey/far-200404-0011_Nezadouci_ucinky_fenotiazinovych_antiemetik_v_detskem_veku.php weekly 0.7 /magno/far/2003/mn1.php weekly 0.7 /artkey/far-200301-0001_Editorial.php weekly 0.7 /artkey/far-200301-0002_New_high-performance_liquid_chromatographic_method_for_therapeutic_drug_monitoring_of_isepamicin.php weekly 0.7 /artkey/far-200301-0003_Hodnotenie_rizika_liekov_vo_vztahu_k_jeho_percepcii.php weekly 0.7 /artkey/far-200301-0004_Farmakologicke_interakce.php weekly 0.7 /artkey/far-200301-0005_Podklady_pro_racionalni_antibiotickou_lecbu_komunitnich_bakterialnich_infekci.php weekly 0.7 /artkey/far-200301-0006_Sucasny_pohlad_na_otazniky_v_liecbe_tuberkulozy.php weekly 0.7 /artkey/far-200301-0007_Farmakoterapie_antibiotiky_u_pacientu_vyssich_vekovych_skupin_vzhledem_k_bakterialni_rezistenci.php weekly 0.7 /artkey/far-200301-0008_Doporuceni_pro_lecbu_inzulinem_u_dospelych_diabetiku_pri_hospitalizaci-navrh_standardu.php weekly 0.7 /artkey/far-200301-0009_Antagoniste_receptoru_AT1_pro_angiotenzin_II_ARB_v_lecbe_hypertenze_STUDIE_LIFE.php weekly 0.7 /artkey/far-200301-0010_-Farmakorezistentni-_hypertenze.php weekly 0.7 /artkey/far-200301-0011_Zprava_z_konferenci_v_Roznove_17_-19_10_2002.php weekly 0.7 /artkey/far-200301-0012_Zapis_ze_schuze_vyboru_Sekce_klinicke_farmakologie_CSEKFT_konane_dne_16_10_2002_v_Roznove_pod_Rad.php weekly 0.7 /artkey/far-200301-0013_Zprava_o_cinnosti_Sekce_klinicke_farmakologie_CSEKFT_za_volebni_obdobi_1999-2003.php weekly 0.7 /artkey/far-200301-0014_Nekrolog_za_prof_MUDr_Andrejom_Nicakom_DrSc.php weekly 0.7 /artkey/far-200301-0015_Devet_desetileti_prof_MUDr_Dr_h_c_Heleny_Raskove_DrSc_2_1_1913.php weekly 0.7 /magno/far/2003/mn2.php weekly 0.7 /artkey/far-200302-0001_Editorial.php weekly 0.7 /artkey/far-200302-0002_Comparison_of_analgesic_effect_of_three_topically_applied_preparations_containing_indometacin-a_p.php weekly 0.7 /artkey/far-200302-0003_Treatment_of_chronic_cough_in_children_with_montelukast_a_leukotriene_receptor_antagonist.php weekly 0.7 /artkey/far-200302-0004_Analysis_of_epilepsy_pharmacotherapy_using_request_forms_for_therapeutic_monitoring_of_antiepilepti.php weekly 0.7 /artkey/far-200302-0005_Uloha_eticke_komise_pri_posuzovaniklinickeho_vyzkumu.php weekly 0.7 /artkey/far-200302-0006_Nezadouci_ucinky_antibiotik_na_gastrointestinalni_trakt.php weekly 0.7 /artkey/far-200302-0007_Salicylany_Aspirin_Acylpyrin_na_prelome_tisicroci.php weekly 0.7 /artkey/far-200302-0008_Nezadouci_ucinky_leku_pouzivanych_v_revmatologii_a_zakladni_principy_monitorovani_jejich_bezpecnost.php weekly 0.7 /artkey/far-200302-0009_Antagoniste_receptoru_AT1_pro_angiotenzin_II_ARB_v_lecbe_hypertenze_studie_SCOPE.php weekly 0.7 /artkey/far-200302-0010_Prevence_cevni_mozkove_prihody_a_systemove_embolie_u_pacientu_s_fibrilaci_sini.php weekly 0.7 /artkey/far-200302-0011_Zprava_ze_4_jarni_konference_klinicke_farmacie_Lisabon_14-17_kveten_2003.php weekly 0.7 /artkey/far-200302-0012_Dexketoprofen_trometamol_pri_lecbe_akutniho_zachvatu_migreny.php weekly 0.7 /artkey/far-200302-0013_Dve_nove_ucebnice_farmakologie.php weekly 0.7 /artkey/far-200302-0014_Prof_MUDr_Jaroslav_Jezdinsky_CSc-70_let.php weekly 0.7 /artkey/far-200302-0015_150_let_od_narozeni_prof_MUDr_Josefa_Thomayera_23_3_1853-18_10_1927.php weekly 0.7 /artkey/far-200302-0016_Vzpominka_na_prof_MUDr_Zdenka_Modra_CSc.php weekly 0.7 /magno/far/2003/mn3.php weekly 0.7 /artkey/far-200303-0002_Circulatory_model_for_glucose-insulin_interaction_after_intravenous_administration_of_glucose_to.php weekly 0.7 /artkey/far-200303-0003_Model_for_evaluation_of_data_from_oral_glucose_tolerance_test.php weekly 0.7 /artkey/far-200303-0004_Benzodiazepiny_v_roce_2002_z_pohledu_vydeje_v_nekterych_lekarnach_a_nalezu_Toxikologicke_laboratore.php weekly 0.7 /artkey/far-200303-0005_Leciva_a_chiralita.php weekly 0.7 /artkey/far-200303-0006_Lekove_interakce_na_urovni_cytochromu_P450-Cast_I_Interakce_na_urovni_CYP3A4.php weekly 0.7 /artkey/far-200303-0007_Proarytmie-zavazne_neziaduce_ucinky_liekov.php weekly 0.7 /artkey/far-200303-0008_Moderni_nesteroidni_antirevmatika_klady_a_zapory.php weekly 0.7 /artkey/far-200303-0009_Moznosti_terapie_infekci_zpusobenych_vankomycin-rezistentnimi_enterokoky.php weekly 0.7 /artkey/far-200303-0010_Kombinovana_lecba_asthma_bronchiale_u_deti.php weekly 0.7 /artkey/far-200303-0011_Standardna_farmakoterapia_a_liecba_komplikacii_u_pacientov_po_transplantacii_pluc.php weekly 0.7 /artkey/far-200303-0012_Soucasne_moznosti_-starsich-_antibiotik_v_terapeticke_praxi.php weekly 0.7 /artkey/far-200303-0013_Lecba_hypertenze_u_nemocnych_s_ICHS-STUDIE_INVEST.php weekly 0.7 /artkey/far-200303-0014_53_farmakologicke_dny_v_Brne.php weekly 0.7 /artkey/far-200303-0015_Zprava_o_konani_8_mezioborove_cesko-slovenske_toxikologicke_konference.php weekly 0.7 /magindex.php daily 0.7